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Abstract	
Separation, identification, and quantitation of biomolecules within complex matrices 
can be costly and laborious. The gold-coated iron oxide nanoparticles functionalised with 
antibodies selectively developed here recovered the target protein, erythropoietin (EPO), 
from a complex biological matrix. Equine blood serum was spiked with EPO and then 
monitored indirectly and detected directly. Surface-enhanced Raman spectroscopy (SERS) 
was used to monitor the antibody-antigen binding event by comparing the spectra before 
and after protein capture using the extractor nanoparticles. As antibody-antigen binding is 
target-specific, this allowed for pre-screening to indirectly detect the protein. Monitoring 
this antibody-antigen binding event can be also be used as a rapid presumptive test for EPO.  
The captured EPO molecules were then released from the extractor nanoparticles, 
deposited on nanostructured gold substrates, and detected directly by SERS on 
nanostructure gold substrates using a handheld Raman spectrometer. The Raman 
fingerprint identification of the protein was cross-validated using independent ELISA 
analysis. The first model described above established a linear response to the log of analyte 
concentration across the range of 50 nM to 5 pM, with a calculated LOD of 1 pM. The 
second model, utilising aptamers immobilised on a developed SERS-active surface, showed a 
similar relationship between 10 nM to 10 pM analyte concentrations measured, with a 
consistent Raman signal RSD of 4.92% across the surface. The SERS detection modes used in 
this method provided label-free rapid and direct spectroscopic identification of the purified 
analyte from biological fluids. Thus, this project combines SERS nanosensors with a 
handheld Raman spectrometer as a proof of concept for the rapid, selective, and sensitive 
analysis of proteins in biological matrices. The developed methodology can be applied in 
real-world applications to screen proteins at points of care, analytical service laboratories, 
toxicology laboratories, and doping control agencies. 
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Chapter	1 	
[1.1] Significance of study 
Biomarkers within biological fluids, such as blood or urine, are usually present in 
trace or ultra-trace quantities making them difficult to detect. Ultra-trace biomarker 
detection is currently carried out using LC-MS, GC-MS-MS, electrophoresis, electrophoresis, 
blotting, and immunodetection methods (e.g. ELISA). However, protein analysis using these 
techniques is challenging due to costly instrumentation, requirement for highly trained 
labour, cross-reactivity,[1] insufficient limits of detection (LOD), or matrix effects.[2] 
Developing sensitive, rapid, and cost-effective detection tools for biomarkers and illicit 
substances would have both life-saving and ethical implications, leading to improvements in 
the quality of clinical diagnosis services and assisting anti-doping law enforcement agencies 
with their duties. Beyond the laboratory, portable methods of detection for biomolecules of 
interest from a background of confounding species can be broadly applied to a range of 
fields. Illicit substance abuse can affect the health and safety of individuals in a workplace, 
or provide an unjust advantage in a competitive sporting environment if left unchecked.[3] 
On-site spot testing of individuals for such substances may prevent incident and act as a 
deterrent for future offenders.  The in-field detection of pollutants at trace levels can be 
used to monitor ecological systems before reaching critical concentrations and causing 
damage.[4] Such events can cause long-lasting agricultural, environmental, and economical 
ramifications to which prevention may be the only cure. The quality control of foods 
involves routine testing for toxins and pathogens to prevent foodborne illness, and is vital to 
ensure consumer health.  Improved analytical platforms in this area would be highly 
valuable to the global multi-billion dollar food industry.[5] Novel biomolecule detection 
methods therefore have a myriad of prospective applications, with the potential for 
environmental, financial, and health impacts on a global scale.  
When coupled with recognition molecules for the selective identification of analytes, 
nanotechnologies have led to the development of improved biomolecular detection 
techniques.[6] Many materials exhibit unique optical, magnetic, and electronic properties at 
the nanoscale (1-100 nm) not observed in the bulk form. The modification of a nanomaterial 
surface with a selective molecule, such as an antibody, peptide, aptamer, or other 
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recognition ligands, allows for the selective capture of target species onto the surface, 
thereby providing a versatile platform for biomolecule detection.[7] Recognition 
modifications can also enable guided therapies by selectively delivering materials to specific 
cell types for drug delivery,[8] theranostics,[9] and tissue and cell imaging.[10] Once bound, the 
analyte is usually detected through interactions with a recognition molecule, the presence 
of a high response reporter molecule, or changes in the surface properties of the 
nanomaterial.[11] These modes of detection rely on indirect evidence to confirm the 
presence of the target analyte, which may reflect changes in systems affected by the analyte 
rather than the identifying characteristics of the analyte itself. This approach, however, may 
lead to lower selectivity and misleading results when the reporter is detected under 
unintended circumstances.[12]  Our strategy employed a highly efficient and specific 
extractor nanoparticle to selectively capture a trace biomolecule of interest from a complex 
biological matrix.  The capture event itself was monitored to indirectly detect the presence 
of the target analyte.  Once captured, the nanoparticle-analyte complex was then easily 
separated from the matrix, the analyte was released from the nanoparticle, and direct 
spectroscopic identification of the analyte carried out by SERS.  
The development of emerging technologies is often application-driven, and is 
evaluated relative to the currently available technologies.  Factors such as cross-reactivity, 
sensitivity, portability, and cost-effectiveness are the major considerations. Many field 
applications such as forensic analyses, environmental monitoring, and testing for doping 
agents in sports can be unsuitable for laboratory-based analyses; sample transport, 
handling, and processing times add costs and delays, thus limiting the timely availability of 
critical data. The development of our method considered efficiency and portability as 
essential.  Robust low-volume sample handling techniques coupled with a portable 
handheld Raman spectrometer allowed all analyte capture, monitoring and SERS 
measurements to be performed rapidly in the field. The developed technique can be easily 
adapted to any target biomolecule, provided a suitable recognition molecule is available.  
Thus, our methodology can be adapted with tuneable designs or for multiplex analyte 
measurements.  
Our combined separation and detection method aimed to have the following 
features: (i) simple analysis requiring little or no sample pre-treatment; (ii) highly specific 
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capture and separation of a target analyte from a complex matrix with SERS-based 
monitoring; (iii) release of purified target analyte for direct SERS-based analysis and/or 
other cross-validation methods; (iv) semi-quantitation using SERS fingerprint signal 
intensity; (v) portability for the screening of biomolecules in the field and; (vi) customisable 
synthetic method that can be adapted for a wide variety of analytes.  
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[1.2] Introduction 
 The significance of biomolecules 
As human understanding expands to unravel the mysteries of biology, the need to 
detect biomolecules of interest becomes paramount for a broad range of applications.[13-16] 
The presence, absence, or quantity of biomarkers such as proteins can be used to monitor 
and assess the health state of biological systems to assist patient care and is also important 
for anti-doping and forensic practices.[17, 18]  
 
Figure 1 - Erythropoiesis cycle (red blood cell production). 
 
The significance of biomolecules cannot be overstated; they control almost every 
aspect of biological life, and any unrectified imbalance can lead to deleterious health effects 
or death of the parent organism. In humans, there are many well-known biomolecules such 
as insulin, thyroid hormones, and erythropoietin (EPO) which can have drastic health 
impacts on humans. For example, if the body is unable to properly utilise or produce insulin 
to break down sugars due to diabetes, blood sugar levels may rise beyond manageable 
levels (hyperglycemia) which can lead to kidney damage, cardiovascular disease, and nerve 
damage.[19] The natural EPO hormone is used for the control of red blood cell production 
(Figure 1), and recombinant EPO can be used for treatment of several types of anemias. 
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Thyroid hormones are used to regulate metabolism in the body, and their production is in 
turn controlled by a biomolecule known as thyroid stimulating hormone. Thus, to be able to 
treat any kind of imbalance of biomolecules and combat resulting diseases, first the 
quantities of the biomolecule(s) of interest must be known. Therefore, the separation and 
detection of biomolecules is crucial for the understanding and treatment of biological states 
and disease.   
Many substances can have powerful effects on the human body, able to alter 
behaviours, perceptions, and even physical traits, making their regulation necessary for the 
safety of the general population. A diverse range of recreational drugs with varying 
physiological effects exist, and can be broadly grouped into hallucinogens, depressants, or 
stimulants. Due to their ability to impair normal function, the production and sale of many 
of these is illegal.[20, 21] Detecting and correctly identifying these substances, as well as their 
metabolites produced by the body, is therefore vital for forensic science and law 
enforcement. Substances that occur naturally within the body, along with their analogues, 
can also be used to gain a competitive advantage. Recombinant EPO is one such example 
which can be abused by athletes, as doping can lead to increased oxygen carrying capacity 
and superior athletic performance. Insulin has also been banned by the International 
Olympic Committee for non-diabetic athletes, as doping can inhibit protein breakdown 
leading to reduced muscle degradation.[22] As such, anti-doping practices must improve to 
properly detect such abuses in order to maintain sporting integrity.  
 Biomolecule separation and detection techniques 
There are a wide range of techniques currently available for biomolecule detection, 
each with their own associated advantages and limitations. Discussed herein are several 
common techniques used for the analysis of proteins and other biological species.  
 Microscopy is among the earliest techniques used to investigate the world beyond 
the perceptions of the human eye. Single cells, and sometimes even their organelles, are 
often visible through the use of a light microscope, and can be analysed visually.[23] 
Investigation into the molecular composition of these cells in situ requires techniques to 
allow microscopic visualisation, such as chemical staining or the more advanced 
immunostaining. The latter utilises antibodies coupled with fluorescent tags, radiolabels, or 
more commonly enzymatic colour producing reactions to visualise and detect target 
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molecules or sites.[24] Preparation for immunostaining may involve first immobilising cells in 
a process called fixation, which can affect the structure of cells and tissues and can be 
destructive to some antigens. Immunostaining agents can also bind non-specifically to cells 
and tissues, which can cause background issues. To compensate for non-specific binding, 
optimisation of several factors may be required, including binding time, blocking agents, and 
washing procedures.[25] Flow cytometry can overcome some of these limitations, as 
immunostaining of biomolecules, typically on the cell surface, is carried out in a mobile 
solution. Multiple analytes can be differentiated using several different fluorescently 
labelled antibodies. The different types of biomolecules are screened, identified, sorted, and 
quantified by conductivity or optical excitation.[26] However, flow cytometers are expensive 
and the technique is limited to suspended cells only. Furthermore, distinct cell populations 
with similar surface markers are difficult to differentiate, and cells must be permeabilised to 
detect internal contents.  
Purification of biomolecules commonly involves the use of chromatography, the 
separation of mixtures according to their physical properties. For proteins in particular, 
chromatography separates molecules on the basis of size, charge, hydrophobicity, and 
binding affinity (Table 1).[27] After separation of a mixture using chromatography, 
appropriate detection methods such can be chosen depending on the analytes. The main 
drawback is that many column chromatography methods require bulky and expensive 
equipment, operator expertise, and method optimisation to sufficiently resolve similar 
species.  
 
Table 1 - Comparison of common chromatography techniques used for biomolecule separation. 
CHROMATOGRAPHY 
TECHNIQUE 
SEPARATION 
PARAMETER 
ADVANTAGES DISADVANTAGES
SIZE-EXCLUSION Size Simple, fast, cheap, mild 
conditions 
Poor resolution of similarly sized species, 
difficult to fine-tune 
ION EXCHANGE Charge High flow rate may recover 
active protein, high yield 
Pretreatment required, needs low salt 
buffers, resin and equipment expensive, 
pH conditions may cause denaturation 
HYDROPHOBIC 
INTERACTION 
Hydrophobicity Mild conditions allows for 
high recovery of natively 
folded protein 
Column and equipment costs, buffer MP 
must be suitable for analytes to retain 
activity 
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REVERSE PHASE Hydrophobicity Readily available, simple 
optimisation 
Column and equipment costs, larger 
proteins are rapidly denatured by harsh 
solvent conditions 
 
Size-exclusion chromatography is perhaps the simplest of these. Columns are 
typically packed with a tuneable porous medium, which retards the flow of smaller particles 
able to travel through the packing material. Larger molecules are excluded from entering 
the packing material, allowing them to flow through the column relatively unimpeded.[28] 
This allows for rapid separation of large species from small, however it is not effective for 
the separation of multiple species of comparable size.  
In ion exchange chromatography, mixtures to be purified are carried across an ion 
doped resin stationary phase (SP) using a pH controlled mobile phase (MP), and the analytes 
are separated according to their surface charges.[29] Molecules with charges opposite to the 
SP displace adsorbed MP ions as they are carried through the column, thereby interacting 
with the SP more frequently and being retained for a longer time. The important 
parameters of this technique are column selection and pH control, which must combine to 
create an environment in which there is a significant charge difference between the target 
and the contaminants. The pH may vary by up to 1 unit from that of the MP at the SP 
interface depending on the resin used. This restricts the pH to within the tolerance of the 
desired target and may denature proteins.  
Hydrophobic interaction chromatography is a specific form of reverse phase liquid 
chromatography, useful for protein analysis.[30] It involves the passing of proteins across a 
hydrophobic SP using a buffer MP. Due to the presence of hydrophobic amino acid residues, 
the surface of protein analytes can have regions of high hydrophobicity leading to attraction 
toward other hydrophobic surfaces, in this case the SP, in a salt-rich aqueous environment. 
The extent of analyte hydrophobicity determines the degree of interaction with the SP, 
which affects the retention time of the analyte on the separation column. Due to the milder 
conditions, this method allows for high recovery of natively folded proteins.  
Reverse phase (RP) chromatography for proteins involves similar principles to 
hydrophobic interaction chromatography, where a polar MP is passed over a non-polar SP 
to elute hydrophilic species before hydrophobic ones. However, analytes must be 
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considerably more hydrophobic in RP chromatography, so much so that adsorption onto the 
SP may occur in pure water. These interactions can be so strong that desorption and elution 
away from the SP requires the use of gradient elution with increasingly non-polar MP 
mixtures. This allows for the sequential elution of increasingly non-polar compounds to be 
separated, which can then be individually detected. The use of non-polar eluents may have 
a denaturing effect on proteins, affecting downstream characterisation.  
 
 
Figure 2 - A typical gel electrophoresis setup. 
 
In addition to size exclusion chromatography, size-based separation of 
macromolecules such as proteins can also be achieved using gel electrophoresis. This 
technique uses a permeable gel to separate a mixture based on a combination of 
electrostatic and friction forces (Figure 2). Gels are commonly made of agarose or 
polyacrylamide, and mixtures loaded into sample wells at one end. A potential is then 
applied across the gel, causing the components to migrate according to charge sign and 
strength. Migration rates are determined primarily by a combination of the forward 
electrostatic force applied by the electric field and the retarding force of friction caused by 
the gel viscosity. Proteins can be separated based on either their native folded structures or 
the molecular weight of the denatured polypeptides, which are then visualised by 
transferral to a membrane for immunostaining before detection. A similar form of gel 
electrophoresis, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), 
utilises sodium dodecyl sulfate (SDS) to denature proteins. These then migrate and separate 
from other macromolecules by polyacrylamide gel electrophoresis according to a 
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combination of charge, length, and conformation. SDS-PAGE is typically sensitive to 
picogram levels of analyte, but does not provide information about the folded protein and 
can be subject to cross-contamination or species conversion effects.[31] After completion, 
additional visualisation or detection techniques are used to observe the separated species. 
Though the technique is relatively straight forward, care must be taken not to overload the 
gel lanes and cause smears or streaking (Figure 3). Electrophoresis is a simple and powerful 
analytical technique, especially when combined with other techniques[32].  
 
Figure 3 - Examples of (A) good and (B) poor SDS-PAGE electrophoresis plate results after visualisation. 
 
The most diverse range of immunoseparation methods, broadly referred to as 
immunoassays, takes advantage of the antibody-antigen interaction to separate the target 
protein from a complex matrix. Immunoseparation methods use a label molecule coupled 
with either antibody or antigen immobilised to indirectly detect and/or quantify the antigen 
after antibody-antigen binding. In immunoassays, a ligand binding event can cause changes 
to the conformation, charge, or optical properties of the recognition molecule. These often 
minute changes can be detected using spectroscopic, amperometric, or potentiometric 
techniques.[33] By immobilising target-specific antibodies onto a suitable substrate, a desired 
ligand can be exclusively captured and extracted from a background of potentially 
interfering species or directed to a target location. These methods can work on competitive 
or non-competitive principles, in single antibody or two-site ‘sandwich’ format (Figure 4). 
Enzyme-linked immunosorbent assay (ELISA) is a popular technique that utilises a 
combination of a specific antibody-antigen interaction along with an enzyme-substrate 
reaction for colorimetric detection. These types of detection utilise label molecules, often 
fluorescent species, to rapidly detect the analyte of interest. This is an important distinction, 
in that it is the labelling molecule being detected to indirectly indicate the presence of the 
(A) (B) 
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analyte, rather than detecting the analyte directly.  The limit of detection for 
immunoseparation techniques depends on a wide variety of factors, and is especially 
contingent on the antibody-antigen binding affinity which can vary by up to 7 orders of 
magnitude.[34] Immunoassay-based technologies are attractive for in-field applications, as 
they can be effectively miniaturised.  
 
Figure 4 – Several types of immunoassay for the detection of biomolecules. In the one step competitive 
assay, labelled analytes held by the antibody are replaced by non-labelled analyte (left-top). The two step 
non-competitive assay, open antibody sites are filled with analyte (middle-top), then remaining sites are 
occupied by labelled analyte (middle-bottom). Non-competitive two-site assays uses an immobilised 
primary antibody to capture the analyte, onto which a labelled secondary antibody then binds (right). 
Detected species are shown in red boxes; in each case, detection is indirect, relying on the presence of a 
labelled species.  
 
Mass spectrometry (MS) is a powerful technique that provides qualitative and 
quantitative information about the target analyte. This detector is traditionally coupled in-
line with HPLC for the separation and detection of proteins in biological fluids, 
environmental samples as well as pharmaceutical preparations. In MS, the separated 
analytes are first vaporised and ionised. The generated analyte ions and fragments are then 
uniformly accelerated under vacuum and passed through a bent path where they are then 
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deflected by electromagnets before detection (Figure 5). The mass and charge of the ion 
determine the degree of deflection, and is expressed as a mass-to-charge ratio (m/z). This 
provides information on the masses of molecular ions, the intact molecule sans electron, 
and their fragments.[35] MS is especially valuable for protein analysis as fragmentation 
patterns can provide structural information, and can be used to identify a particular protein.  
 
Figure 5 - Schematic diagram of typical mass spectrometry system along with example output spectrum 
[Image courtesy of Thermo Fisher Scientific]. 
 
Matrix-assisted laser desorption/ionisation-coupled time of flight mass spectrometry 
(MALDI-TOF MS) is a variation of MS that is often used for protein analysis to detect the 
intact molecular ion. Aqueous analyte is mixed with the matrix solution consisting of an 
organic solvent, proton source, and a polar molecule capable of strongly absorbing within 
the UV or IR range. The mixture solvent is then allowed to evaporate on a MALDI plate, 
leaving behind the recrystallised matrix with embedded analyte ready for measurement. 
The co-crystallised matrix is then typically pulsed with a nitrogen laser (377 nm) to desorb 
and ionise the sample. This leads to the formation of deprotonated species, cation radicals 
and, in the presence of a proton source, protonated species.[36] A time-of-flight mass 
spectrometer then uses a strong electric field to accelerate the ions under vacuum through 
a void space. The time taken to reach the detector through the void space is then used to 
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determine the m/z along with the molecular mass of the intact molecular ion. The running 
costs of MALDI-TOF MS are relatively inexpensive, but initial instrument purchase is costly. 
As MALDI is a soft ionisation process, with little residual energy imparted to the analyte, 
fragmentation is less likely. Therefore, protein identification can only be achieved crudely by 
comparing the molecular ion, rather than fingerprint-like comparisons using characteristic 
fragmentation patterns.  
Exciting new technologies that combine nanomaterials with existing analytical 
methods are now emerging, such as nanoelectromechanical systems resonator based mass 
spectrometry (NEMS-based MS). This technology potentially provides for real-time 
acquisition of spectra, molecule-by-molecule. It can detect high molecular weight molecules 
such as proteins (>500 kDa), including neutral species, with very high mass resolution down 
to a few Daltons.[37] Nanomaterial-based technologies such as this show promise to grow 
and help shape the future of the sciences.  
 Raman spectroscopy for biomolecule detection 
Raman spectroscopy can be used to investigate molecular vibrational modes, similar 
and complementary to infrared spectroscopy. This technique utilises monochromatic light 
to excite the sample from the ground state to a short-lived virtual excited state, and then 
measures the resulting scattering of inelastic photons using a CCD detector (Figure 6). The 
number of scattered photons is directly proportional to the concentration of analyte, and 
can therefore be used to quantify samples. These inelastically scattered photons are either 
of a lower or higher energy than the incident radiation, known as Stokes and Anti-Stokes 
shifts respectively (Figure 7). The difference in wavelength between the incident and 
scattered radiation is used to generate peaks, which provide information about the present 
chemical bonds.[38] These inelastic scattering events describe specific vibrational and 
rotational modes, which can yield a uniquely characteristic, fingerprint-like spectrum. This is 
particularly useful when analysing unknown samples, where peak positions and their 
relative intensities can be compared to a reference spectrum for rapid qualitative 
identification. 
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Figure 6 - Schematic diagram of a Raman spectrometer setup with NIR laser and microscope attached.[39] 
 
 
Figure 7 – Simplified diagram comparing energy transitions monitored by infrared, Raman, and fluorescence 
spectroscopies. 
 
These scattering photons are both infrequent and of lower intensity, approximately 
10-10 fewer than the excitation photons. Due to the infrequency of these scattering events, 
Raman measurements can be limited by sample concentration or require significant input 
energy to acquire sufficient detector counts. As a result, exposing sensitive samples at the 
required power to obtain a Raman signal can induce photo-damage during excitation, which 
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renders this mode of detection undesirable for sensitive analysis. However, phenomena 
capable of significantly enhancing Raman signals are available that allows low power Raman 
spectroscopy analysis for precious samples.  
 Surface-enhanced Raman spectroscopy (SERS) 
Surface-enhanced Raman spectroscopy (SERS) is an enhancement technique that can 
improve the Raman intensity of analytes in the proximity of a roughened noble metal 
surface by several orders of magnitude.[40, 41] This ability to address the sensitivity 
limitations of the parent Raman technique, whilst also providing spectroscopic information 
for the potential identification of the analyte, was a promising detection technique for this 
project. 
The ability to significantly amplify weak Raman signals by several orders of 
magnitude when close to a nanostructured noble metallic surface makes SERS a valuable 
tool for the identification and quantification of ultra-trace amounts of Raman-active 
compounds.[42] Enhancement is distance dependent, with an inverse relationship between 
signal strength and metal proximity, however, steady enhancements have been observed as 
far as 30 nm from the surface.[43] The exact mechanism of the SERS enhancement is still 
debated in the literature, but the two main mechanisms proposed for the enhancement 
phenomenon are the electromagnetic (EM) effect and the chemical effect, with major 
contribution from the EM effect.[44] The chemical effect is comprised of contributions from 
metal-adsorbate bonding, charge transfer, image dipole enhancements, effective 
polarizability, and surface resonance. The EM effect includes contributions from the image 
field effect (IFE), the lightning rod effect, and the surface plasmon resonance (SPR) effect. 
SPR arises when surface plasmons in a SERS-active substrate are excited by incident light. 
This is most effective when the wavelength of the excitation radiation matches with, or is 
close to, that of the surface plasmon resonance of the metal.[45]  The most commonly used 
SERS-active metals are silver and gold, as their excitation wavelengths are in or near the 
visible range, although copper, palladium, or platinum can also be used.[46] The magnitude 
of the SPR effect is influenced strongly by size, surface structure, shape, and proximity to 
other SERS-active surfaces.  In the case of noble metal nanoparticles, multiple particles in 
close quarters can cause coupling effects between the surface plasmons at the interfaces of 
adjacent particles, thereby drastically increasing the localised SPR field (LSPR) within 
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interstices of clustered nanoparticles.[47] This type of interaction produces regions of 
incredible signal enhancement referred to as “hot spots”, potentially capable of single 
molecule detection (Figure 8).[48, 49] LSPR is observed when the wavelength of the excitation 
light exceeds the nanoparticle size, with increasing field intensity nearer to the particle 
surface. However, enhancement may not be uniform across all regions of the spectrum, 
even between replicate measurements, and some form of spectral averaging is often 
required to obtain reliable spectra. Furthermore, SERS enhancement of interfering species 
may complicate spectral interpretation or convolute diagnostic peaks. The non-homogenous 
distribution of such hot spots on the SERS substrate surface can contribute to variations in 
signal intensity between sample measurement sites.[50] When working with ultra-low 
analyte concentrations or molecules with poor Raman cross-sections, significant variations 
in the SERS signal intensity, known as SERS blinking, may arise. These blinking effects can 
affect SERS-based quantification using point-and-measure techniques, and there are many 
contributing factors that are still poorly understood.[51] To alleviate inconsistencies in the 
SERS signal intensity, labelling or reporter molecules such as Raman-active dyes or other 
strong Raman scatterers can be used to produce an intense Raman response that facilitates 
extrinsic detection.[52] However, the high signal intensity of the Raman reporter often 
precludes the direct detection of the target analyte Raman fingerprint. By using indirect 
detection, the user is forced to assume that the detection of the labelling molecule 
correlates to the presence of the target analyte, which may be quantitatively misleading or 
create a false positive result.  
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Figure 8 - Electromagnetic amplification of Raman signals via LSPR and resulting 'hot spot' SERS 
enhancements. 
 
The main attraction of the Raman signal enhancement provided by SERS is 
undermined by the lack of selectivity when a bare substrate is used for the measurement. 
This lack of selectivity causes impure samples to produce complex SERS spectra that are 
nearly impossible to deconvolute. As such, SERS measurement is usually preceded by 
significant sample preparation and pre-treatment procedures in order to obtain reliable 
data from the target analyte. These purification procedures can be simplified or eliminated 
by developing an analyte-specific recognition layer directly onto the nanostructured surface 
in order to produce simple and effective analyte-specific SERS-based tools that are tailored 
to each application. 
 Recognition molecules for selective SERS 
To selectively capture an analyte of interest, a suitable high affinity recognition 
molecule is required.  Natural recognition molecules such as antibodies and aptamers 
exhibit a high degree of specificity towards their associated ligands. 
 Antibodies and their fragments 
 Naturally occurring antibodies are large bidentate binding proteins that are able to 
bind to specific target molecules (antigens), and are used by the immune system to 
recognise potentially harmful pathogens. Also known as immunoglobulin (Ig), antibodies are 
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a class of proteins with a high degree of selectivity.  The structure (Figure 9) and binding 
mechanisms of antibodies have been extensively studied.[53]  
 
Figure 9 - General structure of an antibody. 
 
The heterotetramer structure is similar across all Ig antibodies, with each region 
consisting of conjoined chains subdivided into a combination of constant domains (C) and 
variable domains (V) for both the large heavy chain (H) and small light chain (L). The heavy 
chain consists of four regions; one upper VH domain which makes up half of the antigen 
binding site, linked to the CH1 domain, which is then bound via a flexible hinge region to the 
lower CH2 and CH3 domains. The light chain contributes the other half of the binding region 
from its VL domain, followed by a CL domain. The upper half of the antibody (VH, CH1, VL, CL) 
is known as the fragment antigen-binding (Fab) region. The lower half of the antibody (CH2, 
CH3) is the fragment crystallisable (Fc) region, which interacts with surface receptors and is 
responsible for immunogenicity of the antibody. The light and heavy chains are held 
together by disulfide bridges between the CH1 and CL domains for each prong, and the two 
prongs are linked via similar disulfide bridges between the two hinge regions. This gives the 
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antibody its characteristic Y-shaped structure, with either antibody binding site (paratope) 
able to independently bind its antigen via its complementary recognition site (epitope). 
Although the antibody-antigen binding interaction is analogous to a lock-and-key 
mechanism, the true nature of binding is somewhat more nuanced. As both the VH and VL 
domains contribute to the effectiveness of the complementarity-determining regions (CDRs) 
of the paratope, it is a combination of both that is responsible for the antigen specificity, 
known as combinatorial diversity.[54] Each antibody can therefore bind to one or two 
antigens, via one or both binding sites, depending on the present CDRs. In the case of 
smaller molecules or peptides, the antigen may be captured by internalisation into a cavity 
within the binding region, leading to detectable conformational changes in the antibody 
structure.[55, 56] Large antigens that are too bulky to fit within the confines of the antigen 
binding site, must bind over a larger area via their CDRs. Antibody-antigen binding involves 
weak forces such as hydrogen bonding, electrostatic forces, Van Der Waals forces, and 
hydrophobic forces. These are reversible noncovalent interactions and can be easily 
disrupted by pH extremes, salt concentration, detergents, and even the presence of excess 
epitope.[57]   
 In order to reduce complexity and decrease the size requirements of antibodies 
while retaining function, smaller antibody fragments have been developed. These include 
cleaved antibodies, antigen-binding fragments (Fab), single chain variable fragments (scFv), 
and 3rd generation (3G) technologies such as single domain molecules.[58] Cleaved antibodies 
are bifurcated by reducing the disulfide bonds holding the two heavy chains together. 
Thusly reduced antibody may be attractive for noble metal surface applications due to the 
availability of free thiol linkages. Antigen-binding fragments consist of individual cleaved Fab 
regions of the antibody. Compared to intact antibody, Fab fragments have the additional 
advantage of reducing the chance of triggering an undesirable immune response in the 
absence of the Fc region. Single chain variable fragments consist of the VH and VL antigen-
binding domains. However, scFvs are not produced by cleavage from the neighbouring 
constant domains on their respective chains, but rather by protein fusion of the variable 
domains using a short peptide chain. As the name implies, single domain molecules consist 
of one variable domain, able to bind to a target with a lower degree of specificity due to the 
effective halving of the paratope. While these antibody fragments show potential for 
19 
 
recognition applications, the impact on their binding efficiencies and how the reduced size 
affects conformational changes are not yet well understood.  
 Aptamers  
Aptamers are short single stranded chains of DNA, RNA, or peptides able to 
recognise and bind to a target molecule with a high degree of specificity. Aptamers bind to 
their antigen targets by forming complementary secondary and tertiary structures.[59] DNA 
and RNA aptamers are small in size, typically between 20-60 nucleotides and bind 
completely, whilst peptide aptamers are larger and bind only using a small portion of 
variable sequence, analogous to antibodies. To form the binding aptamer complex, 
complementary bases form secondary structures such as loops or helices which further fold 
into tertiary structures. These are then able to recognise and bind to the antigen through 
weak noncovalent interactions such as electrostatic and hydrophobic interactions.[60] As the 
aptamer binding site is largely random, the function of the ligand can be blocked upon 
aptamer binding.[61] Specific aptamers are raised against a target in vitro using a process 
called systematic evolution of ligands by exponential enrichments (SELEX), and can be easily 
amplified or synthesised at a fraction of the cost relative to antibodies. When compared to 
the 3-6 month shelf-life of antibodies, aptamers are far more stable, and can be stored dry 
at ambient temperatures or kept frozen in a suitable buffer solution at -20˚C indefinitely.[62]  
Biological systems often contain nuclease enzymes, capable of cleaving the 
phosphodiester bonds between the nucleotides of aptamers, which is problematic when 
working in biological mediums. This renders stock aptamers ineffective, however there are 
several modifications that can impart resistance against nuclease degradation, such as 
chemical modification of the nucleobases or reverse-polarity capping of the termini.  
 Nanomaterials for biological separation 
There is a wide array of types and sizes of nanomaterials, such as nanorods, 
nanoparticles, nanostructured surfaces, nanofibers, quantum dots, and nanofilms. Each of 
these nanomaterials possesses varying properties which can be tuned to fit a specific 
requirement. These are materials with nanoscale dimensions (1-100 nm) of their 
superstructure or textured surface, and exhibit properties not observed in the bulk material. 
When considering liquid biological separation using nanomaterials, applications can be 
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broadly classified into two categories, surface-immobilised capture or dispersion capture, 
each with their own merits.  
 Surface-immobilised separation methods 
Surface-immobilised methods of separation involving selective retention of target 
analytes, where mobile samples are passed across a stationary nanostructured surface to be 
captured and detected. These nanostructured surfaces include nanocoated surfaces, 
nanocomposite surfaces, and nanostructured surfaces. Such nanomaterials are desirable 
due to their on-line measurement capabilities and ease of use. Nanocoated surfaces are 
those which have a nanometre scale coating on the surface to impart desirable properties, 
such as the popularised superhydrophobic coatings, or functionalised magnetic beads for 
bioseparation. Nanocomposites are made up of multiple distinct nanomaterials, imparting a 
mixture properties that are unavailable in traditional composites.[63] Nanostructured 
surfaces are often covered in jagged structures such as pillars, spikes, or cones, which confer 
a far greater overall surface area than featureless surfaces. Noble metal materials with 
sharp angled surfaces are capable of amplifying Raman signals. These tips are areas of 
localised surface plasmon field enhancement which are the basis of specialised techniques 
such as tip-enhanced Raman spectroscopy (TERS) for nanometre scale spatial resolution.[64, 
65]  
Nanomaterial surfaces can be prepared using a variety of techniques, including 
electrochemical deposition,[66] lithography,[67] and colloid deposition.[68, 69] These surfaces 
can be functionalised by forming self-assembled monolayers (SAM), an immobilised and 
uniform sheet of packed molecules over the metal which provides an ideal mechanism for 
tuning the surface properties. By depositing molecules over a surface of known area, the 
loading capacity of the surface can be easily calculated. By creating a SAM composed of 
recognition molecules over gold or other noble metal surfaces, chemical and physical events 
occurring on the surface (e.g. binding event between an antibody and antigen) can be 
monitored. This can be observed through changes in optical properties,[70] electrochemical 
properties,[71] or changes in LSPR oscillations,[72] and is the basis for many types of 
biosensor. Although immobilised separation methods allow for simpler sample 
measurement, they are often not suitable for in-vivo or ex-vivo measurement due to size 
constraints and potential cytotoxicity of the platform material.  
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 Dispersion separation methods  
 Nanomaterials able to stay freely suspended within their medium boast several 
advantages over immobilised surfaces related to their mobility, as well as possessing a high 
surface area to volume ratio. Nanomaterials, including nanoparticles, nanorods, 
nanoflowers, and quantum dots, exhibit a wide range of properties that can be tuned 
similarly to nanosurfaces through the use of composite materials or the addition of SAMs. 
Functionalisation using recognition molecules can allow dispersed nanomaterials to act as 
either platforms for analyte capture, or as mobile vectors for specific regions or tissues. 
Depending on their size, the surface area of these materials can accommodate a high 
loading capacity of recognition molecules on their surface. Due to the increased freedom of 
movement, collection of these materials after dispersion can be more difficult. Common 
concentration and collection techniques involve centrifugation, targeted accumulation, or 
magnetic extraction for compatible materials.  
 Gold nanoparticles as versatile targeting platforms 
Gold nanoparticles (AuNPs) have been popularised due to a variety of attractive 
properties such as potential biocompatibility,[73-75] photothermal therapy and imaging 
capabilities,[76] plasmonic properties,[77] optical properties, and ease of functionalisation.[78]  
Although gold NPs are often considered biologically inert at low concentration,[75] the exact 
nature of their cytotoxicity is still a matter of debate.[73, 74] The ability to form strong 
covalent bonds between gold and thiolated compounds (e.g. thiolated aptamer, reduced 
antibody, and antibody fragments), makes it an ideal metallic surface for functionalisation. 
Amine- and carboxy-terminated species can also bind to gold via their lone pairs of 
electrons, although these bonds are weaker than the Au-S bond.[79] In addition, this type of 
bonding is non-specific and can lead to cross-linking aggregation of nanoparticles.[70]  
Noble metal surfaces utilising coupled recognition elements are often used to 
capture a target analyte onto the parent substrate, but can also be used to direct free-
moving nanomaterials to a target location. Localised concentration of such materials can 
therefore be used to enhance the SERS signal of the bound target site, enabling SERS 
characterisation of relatively large species, such as cells.  
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 Hybrid nanomaterials as customisable platforms 
The development of nanocomposites materials consisting of a magnetic material and 
noble metal coating allows retention of desirable properties along with rapid magnetic 
separation with minimal physical stress. Due to their potential cytotoxicity, magnetic 
nanoparticles such as iron oxides are often coated with a protective shell prior to 
functionalisation to impart biocompatibility and tune the NPs properties for a wide variety 
of applications.[80] Coating may consist of a noble metal, polymers, or silicates. The ability to 
easily functionalise noble metal surfaces, selectivity of the particles towards particular cell 
types, concentration of analyte prior to detection, and biocompatibility makes them ideal 
for biomedical applications. Core/shell configurations comprised of iron oxide nanoparticles 
coated in noble metals are popular due to their size-tuneable plasmonic properties and 
potential for biomedical applications.[81] Furthermore, the array of available detection 
modes such as visual detection and colourimetry,[82] UV-Vis spectroscopy, MRI, X-ray 
computed tomography (CT),[83] and SERS makes these magnetic nanomaterial hybrids a 
diverse multi-modal detection platform. 
 Erythropoietin  
 Although a sparse array of biomarkers are available, Erythropoietin was chosen as a 
model protein for this study due to its significance in clinical diagnosis, sports doping, and 
the treatment of anaemia. Erythropoietin is a glycoprotein hormone produced 
predominantly in the kidneys used to stimulate red blood cell production (erythropoiesis) in 
the bone marrow, and is an effective treatment for many forms of anemia including those 
related to cancer therapy. EPO is a highly glycosylated protein of approx. 30 kDa size, with 
naturally produced (endogenous) and synthetic recombinant (exogenous) types, which can 
be differentiated by variations in their glycosylation patterns (Figure 10). Recombinant 
human erythropoietin (rHuEPO) can be produced by inserting DNA coding for the protein 
into the genomes of bacterial or eukaryotic systems, although additional post-translational 
modifications may be required.[84] Such modifications by non-native organisms can produce 
variations in the mature protein that can be used to differentiate the exogenous and 
endogenous isoforms.[85]  
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Figure 10 - Predicted structure of glycosylated human erythropoietin with three N-linked glycans (purple) 
and one O-linked glycan (pink).[86] 
 
 The structure of EPO consists of 165 amino acids and four carbohydrate groups with 
a circular polypeptide chain. EPO contains two disulfide bridges, the first of which completes 
the circular structure between cysteines 7 and 161, and the second between cysteines 29 
and 33. The former bridge is particularly crucial as it is responsible for holding the molecule 
in the correct shape for binding to the erythropoietin receptor.[87]  
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Figure 11 - Primary structure of erythropoietin, with disulfide bridges (S-S) and carbohydrate groups (CH).[87] 
 
Doping of EPO or erythropoietin-stimulating agents (ESA) can lead to increased 
oxygen uptake due to an increase in red blood cell proportions in blood (haematocrit). This 
increase in haematocrit can improve respiration of muscles through improved oxygen 
uptake and delivery, translating to improved endurance and athletic performance. For these 
reasons, doping with EPO and ESAs has been banned by the World Anti-Doping Agency 
(WADA) since the early 1990s. However, reliable tests for EPO weren’t available until the 
year 2000, where they were introduced to the Summer Olympic Games in Sydney.[88] Blood 
doping of EPO and ESAs in sports such as horse racing, greyhound racing, cycling, boxing, 
rowing, and other endurance events continues to fuel the evolution of new forms of these 
substances. As a result, analysis methods must constantly improve in order to keep up with 
these changes. 
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[1.3] Literature review 
The presence of absence of biomolecules such as proteins can be indicative of the 
health state of a biological system and is a fascinating area of study. Erythropoietin in 
particular is a protein of interest due to its use as a blood doping agent in sports, as well as 
its overexpression in certain types of cancers. The detection of proteins at clinically relevant 
levels is often expensive and laborious. As such, the development of new methods able to 
both qualitatively identify and quantitate biomarkers quickly and easily can have 
widespread applications. Raman spectroscopy, specifically SERS, was identified as a 
technique with great potential in this regard, as it is capable of providing information on 
both the chemical bonds and quantity of analyte at ultra-trace concentrations under 
controlled conditions. Therefore, this review will follow the development and applications 
of SERS-based methods of biomolecule detection, and any relevant literature regarding 
detection of the EPO protein.  
 Biomolecule detection within pure samples 
 AgNPs and SERS for biomolecule detection 
The most common metals used for SERS enhancement are silver and gold, as both 
provide enhancement when stimulated by radiation of visible or NIR wavelengths. Silver is 
typically less expensive than gold. Despite the fact that Ag can deliver higher SERS enhancement, 
it is very liable to oxidise and consequently loses its SERS activity. Therefore, gold nanoparticles are 
more suitable candidates to applications in the biomedical area due to their very high stability in 
biological environments. In addition, Ag nanoparticles can cause damage to biological systems. 
To prevent this, silver nanoparticles were encased in a passivating iodide layer and direct 
interaction with the metal surface was prevented, imparting biocompatibility toward tested 
proteins.[89] The iodide protected silver nanoparticles were able to provide SERS spectra of 
lysozyme with comparable profiles to normal Raman, and outperformed similarly modified 
and tested gold nanoparticles, whilst keeping tested proteins intact.   
 Bare AuNPs and SERS for biomolecule detection 
 The close proximity of an analyte to a noble metal NPs surface can lead to SERS 
signal enhancement, and can be enormously amplified through particle aggregation. A 
previous 2004 study showed that particular species, in this case rhodamine 6G (R6G), 
normally difficult to detect on gold substrates, yielded SERS enhancement of 107 – 109, 
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which was attributed to the surface properties and strong NIR absorption of the aggregates 
used.[90] The use of enhancing noble metal nanoparticle aggregates has since become more 
widespread, with more advanced methodologies employed to generate these NP clusters.  
Microfluidic devices direct liquids to active sites through small channels, with potential for 
low volume and high throughput processing, multiplexing capabilities, and automation. By 
using a polydimethylsiloxane chip and constricting a downstream microvalve, researchers 
were able to dam the flow of AuNPs in a microfluidic device and cause reversible 
aggregation to create hot-spots for the on-line measurement of bovine serum albumin (BSA) 
by Raman.[91] The microfluidic chip was able to attain a detection limit for BSA at picomolar 
levels, on par with mass spectrometry. This method of detection is limited by sample purity, 
as unwanted species may affect the SERS measurement in the presence of the enhancing 
AuNP aggregates.  
 Immuno-AuNPs for biomolecule detection 
The optical absorption of AuNPs within the visible region can be exploited to prepare 
simple yet elegant visual tests. A lateral-flow immunoassay dipstick for aflatoxin B2 (AFB2) 
detection was developed using iron oxide cores decorated with AuNPs and functionalised 
with anti-AFB2 antibodies, which allowed the rapid and simple visual detection.[92]  
 Although many methods of specific biomolecule separation utilise nanomaterials 
with anchored separation entities, surface functionalisation may also occur using weaker 
interactions such as adsorption. In the case of AuNPs, increasing the ratio of nanoparticles 
or peptides in solution has been shown to induce or reverse aggregation, respectively.[93] 
This method of aggregation control is attractive, as UV-Vis spectroscopy showed the effect 
to be reversible without having to manipulate the pH, temperature, or salt concentration of 
the medium. These aggregated clusters of gold nanoparticles can produce hot spots leading 
to high SERS enhancements, increasing detection sensitivity. Within this study, separation 
methods were also demonstrated using single biotinylated AuNPs to extract streptavidin 
from a protein mixture. This method is susceptible to competitive surface interactions such 
as compounds containing thiol groups, which would displace the relatively weakly bound 
adsorbed species onto the gold surface.  
Competitive binding interactions can be exploited to detect species with differing 
binding affinities toward a surface. By utilising an adsorbed SAM of Raman reporter 
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molecules on a noble metal surface, compounds containing thiol groups can be detected 
when they displace the reporter due to their stronger binding affinity, thereby producing a 
decrease in reporter signal.[94] This reverse reporting method was investigated using three 
different Raman reporters, R6G, crystal violet, and 5,5’-dichloro-3,3’-disulfopropyl 
thiacyanine, which were deposited onto a silver nanoparticle surface to detect glutathione. 
A decrease in reporter signal intensity was observed in the presence of glutathione. This 
decrease was attributed in part to the displacement of the Raman reporter by the more 
strongly binding glutathione and the aggregation of the silver colloid. The reasoning for 
displacement is sound, as the proximity of the reporter to the SERS-active surface will affect 
whether its signal will be enhanced by the silver. However, the justification for reduced 
signal intensity due to aggregation is somewhat unclear, as cross-linking and aggregation of 
noble metal nanoparticles often serves to increase SERS signals through LSPR enhancement. 
This detection mechanism is simple, can be used to selectively separate thiol-terminated 
molecules, and has a rapid 20 minute analysis time. However, it does not allow for high 
sensitivity, with a detection limit of ca. 1 µM. The poor sensitivity may be due to the high 
signal intensity produced by the Raman reporters, whereby displacement of a few reporter 
molecules by small quantities of thiol analytes would not produce a sufficiently significant 
signal reduction for reliable detection by SERS. This detection range is not suitable for many 
clinical applications.  
 Hybrid nanomaterials for combined separation and detection of 
biomolecules 
 Functionalised AuMNPs 
A recent study utilised AuMNPs functionalised with a mixed SAM of 3-
mercaptophenylboronic acid and 1-decanethiol to bind to the glucoside moieties expressed 
on the surface of Escherichia coli cells, which were then concentrated using a magnetic field 
prior to SERS measurement.[95] The mixed monolayer system was found to specifically bind 
to the target cells, as demonstrated by comparable SERS spectra between NPs bound to 
both pure E. coli and E.coli extracted from a bacterial growth solution. By functionalising the 
surface to direct localisation towards specific sites, the magnetic properties of such 
nanocomposites can also be harnessed in-vivo as magnetic resonance imaging (MRI) 
contrasting agents. Polyethylene glycol functionalised AuMNPs have been used as negative 
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MRI contrasts to demonstrate specific accumulation within tumor masses of colon cancer in 
mice, and pancreatic adenocarcinoma cells in humans, through the enhanced permeability 
and retention (EPR) effect.[96]  These papers demonstrate the flexibility of mobile noble 
metal surfaces such as composite nanoparticles to act as either selective capturing sites or 
targeting vehicles, streamlines separation procedures using magnetic concentration, and 
enables identification using SERS.  
AuMNPs have also been used to mechanically concentrate bacteria by applying an 
external point magnetic field, attracting added AuMNPs to gather bacteria and particles in 
tightly condensed clusters, reminiscent of a sweeping action.[97] This led to subtle SERS 
spectral differences between three bacterial strains, with strains clearly separated by 
principle component analysis (PCA). The method also detected 4-mercaptopyrine down to 
0.1 ppb. The closeness of individual particles in these clusters led to the formation of hot 
spots, thereby increasing SERS enhancement of present analytes. Such enhancing regions 
can be created in a more permanently way, by creating nanomaterials with closely packed 
nanoparticles or other irregular surface structures. One such method uses a magnetite core 
coated in silica, small AuNP seeds are adsorbed and then fastened with more silica by filling 
inter-particle gaps, and finally the exposed AuNP faces are plated in gold to form a closely-
packed arrangement of bulbous gold, with the overall surface structure arrangement 
reminiscent of raspberries.[98] This allowed for sensitive detection of femtomolar levels of 
Raman-active test analyte, R6G, due to the magnetic concentration of the iron core and 
surface-adsorbed species in a magnetic field, along with the controllable size and 
reproducibility of the high performance SERS-enhancing surface.  
Sandwich immunoassays are a popular approach to detecting target analytes,[99-102] 
and work by capturing a target species between two non-competitive antibodies which 
allows for extreme specificity and sensitivity. Typically, one antibody is immobilised onto a 
surface or NP, and a secondary antibody that identifies a different binding region can be 
coupled with a labelling molecule. The analyte then becomes ‘sandwiched’ between the two 
antibodies and detected indirectly through the labelling molecule. A study aimed at 
developing a SERS detection method for bovine leukemia virus antigen gp51 utilised 
AuMNPs with either randomly oriented anti-gp51 antibody or its half-antibody fragment in a 
fixed orientation as one half of the sandwich, and gold nanorods with a mixed layer of anti-
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gp51 antibody and a Raman-active label, 5-thionitrobenzoic acid (TNB), as the other half.[103] 
The method demonstrated antibody fragments to be more advantageous, and LOD and LOQ 
were found to be 0.95 µg mL-1 and 3.14 µg mL-1, respectively. The method was also able to 
detect gp51 in milk. A similar approach using sequential antibody-based AuMNP extraction 
followed by SERS detection, where reporters consisting of gold nanorods bearing antibodies 
and TNB to quantify E.coli with LOD and LOQ of 8 and 24 cfu mL-1, respectively.[104] A similar 
study to detect Staphylococcal enterotoxin B (SEB) evaluated two sandwich assay types. The 
first type was a heterogeneous assay that utilised gold-coated glass slides functionalised 
with commercial SEB-specific aptamer. The second system used a homogenous assay 
comprised of magnetic core gold nanorods functionalised with SEB-specific aptamer. For 
SERS detection, both assays used gold nanorods modified with a mixed layer of TNB and 
SEB-specific aptamer as the second component.[105] The homogeneous nanorod assay was 
found to be more sensitive than its immobile heterogeneous counterpart, which was 
attributed to the superior capturing efficiency due to the comparatively higher surface area. 
Detection of SEB was achieved at attomolar concentrations, and allowed quantification 
within complex matrices such as milk, blood, and urine. A recent study demonstrated the 
use of mixed aptamer SAMs in a magnetic sandwich assay to simultaneously capture and 
detect two common foodborne pathogens, Salmonella typhimurium and Staphylococcus 
aureus, using SERS detection.[106] In this work, a capture probe consisting of AuMNPs 
adorned with both S. aureus and S. typhimurium aptamers was used in conjunction with two 
different signal probes. The first probe was AuNPs decorated with S. aureus aptamer and 
TNB. The second probe was AuNPs coated with S. typhimurium aptamers and 
mercaptobenzoic acid (MBA). Once captured, the sandwiched target bacteria were 
magnetically separated and detected by SERS, with detection limits of 35 cfu mL-1 and 15 cfu 
mL-1 for S. aureus and S. typhimurium, respectively. The use of a heterogeneous recognition 
SAM has been demonstrated to accommodate the simultaneous detection of analytes 
without complicating the extraction procedure. These studies illustrate the potential for 
aptamer-mediated binding as an alternative to antibodies, with a trade-off of binding 
efficiency for lower costs, less complexity, and superior long-term stability. An investigation 
into the development of immunoassays with higher binding efficiencies utilised a 
combination of antibody-functionalised AuMNPs for separation and antibody-functionalised 
AuNPs coated with Raman-active labels for SERS-based detection.[107] A mixture of human 
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and mouse IgGs were separated using goat anti-human IgG functionalised AuMNPs and 
remaining IgGs monitored over time using the labelled AuMNP-surface sandwich 
immunoassay. The results showed that the immuno-AuMNPs reduced the concentration of 
human IgG in the mixture whilst leaving the mouse IgG relatively unchanged. This design 
assumes that removal of the target analyte is by specific means only, which is undermined 
by an observed reduction in mouse IgG signal over time. The aforementioned literature 
demonstrates the efficacy of magnetic nanomaterial-based immunoassay methods for 
selective capture and SERS-based detection. Although the inclusion of a Raman reporter 
allows for far greater sensitivity, detection of the target analyte was carried out by indirect 
means and assumes that the reporter presence is a result of specific binding to the target 
analyte. Due to the requirement of sandwich assays to use multiple NP or surface types for 
separation and detection, additional complexity is imparted to the system. The requirement 
of these assays to utilise two non-competitively binding recognition molecules significantly 
adds to the cost of these assays, and can be restrictive if suitable antibody or aptamer sets 
are not accessible.  
 Functionalised MNPs, AuNPs, or AuMNPs used in combination 
 Sets of SERS probes aimed at the detection of the foodborne pathogens Salmonella 
enterica serovar Typhimurium and Staphylococcus aureus within a food matrix were 
developed using tailored sets of magnetic separator particles and SERS probes.[108] Iron 
oxide nanoparticle clusters were group-coated in an APTMS polymer coat with pathogen-
specific antibody used for immunoseparation from a mixture. Additional SERS probes 
consisting of AuNPs decorated with an assigned Raman reporter and antibody for each 
pathogen were then conjoined with the clusters. Using this scheme, 103 cfu mL-1 of the 
target pathogens were detected in spinach. A blind test in peanut butter confirmed the 
detection limit and the specificity of the test. Although the reported sensitivity was fairly 
low, the use of more suitable Raman reporters and SERS substrates than those trialled 
would possibly improve the sensitivity of this method down to the single pathogen level. 
Uncoated magnetic nanoparticles have been used to separate thrombin (TB) using 
aptamer functionalised TBA15-MNPs, and subsequently detected with SERS through 
aptamer-reporter co-functionalised gold nanoparticles, TBA29-AuNP-XRITC.[109] The lower 
limit of the SERS detection was determined to be 0.27 pM. This shows the potential for 
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immuno-functionalised AuNP/MNP systems toward detection of biomolecules at clinically 
relevant concentrations.  
 Immuno-AuMNPs for selective and label-free SERS  
 The use of labels such as Raman-active molecules often allows for greater 
sensitivity, due to their enhanced Raman cross-section, however one must assume that the 
detection of the label corresponds to the presence of the analyte. Furthermore, 
quantification using labelling assumes a correlation between label and target analyte 
concentrations. Methods that utilise label-free SERS detection allow for the presence of the 
analyte to be measured directly. By attaching AuMNPs to a graphene surface and 
functionalising the gold surface with antibodies specific for Alzheimer biomarkers, tau 
protein and β-amyloid, a rapid separation-detection technique was devised with 
femtogram-level sensitivity.[110] The high sensitivity was attributed to the plasmon-coupling 
of neighbouring AuMNPs to form hot spots. However, the HR-TEM images of freshly 
prepared AuMNP-graphene oxide surfaces showed a heterogeneous particle distribution, 
often with large inter-particle distances. Therefore the efficiency and reproducibility of this 
method with respect to SERS signal enhancement may be limited by the random loading 
distribution of the AuMNPs. Popcorn-shaped AuMNPs functionalised with antibodies have 
been demonstrated for targeted magnetic separation and enrichment, and label-free SERS 
detection of the multi-drug-resistant Salmonella DT104.[111] The detection was carried out 
by monitoring the changes in UV-Vis and SERS profiles of the functionalized NPs before and 
after binding to the targeted bacteria. The spectra of the separated bacteria showed 
sequential decreases in SERS intensity that coincide with reduced concentrations, opening 
the door for SERS-based quantitation. The AuMNPs were also used in conjunction with a NIR 
laser to induce photothermal damage to target cells, and monitored by SERS. The selectivity 
of the system and requirement for gold proximity to cause photothermal damage was 
shown by using the Salmonella DT104-specific AuMNPs in a solution of concentrated E. coli 
bacteria, with 97% of the E. coli surviving a laser dose shown to kill 100% of the target 
species. This study demonstrates the versatility of AuMNPs for both separation and 
detection applications, as well as the potential for theranostics. The design of this system is 
quite elegant, with all components serving one or more purposes.  
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 Immuno-AuNPs for label-free SERS separation and detection of EPO 
As stated earlier, SERS can been used to monitor the binding event between 
selective recognition elements and their ligands. In a recent study, anti-EPO antibodies were 
anchored to silica-coated AuNPs and used for label-free SERS detection of the protein in a 
biological matrix.[112] The silica shell was used to prevent non-selective binding to the AuNP 
surface without impairing the signal enhancement. The SERS quantification of EPO using this 
nanosensor was 3.5x10-13 M. This nanosensor demonstrated the suitability of specific 
recognition-coupled nanoparticles as a combined selective extraction and label-free SERS 
detection platforms when coupled with SERS, for proteins at biologically relevant levels. 
However, this study did not provide any direct detection of the analyte. Instead, the method 
monitored the SERS variations attributed to conformational changes within the antibody 
recognition layer upon interaction with EPO. Such spectral variations can be so minor that it 
may be difficult to attribute differences conclusively to antibody-antigen binding events 
rather than other external influences. Furthermore, this mode of monitoring does not allow 
for quantitation of the analyte.  
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[1.4] Aim and scope 
To the best of our knowledge, there have been no reports of a rapid methodology 
for the combined selective separation and label-free direct SERS detection of biomolecules 
in complex biological fluids. Research on SERS-based methods for the direct detection of 
erythropoietin is lacking, with no reported Raman spectrum of an extracted EPO protein 
found in the literature. Thus, our research was aimed at the development and testing of a 
selective extraction system, able to separate biomolecules from complex biological samples, 
coupled with label-free SERS detection and quantitation capabilities. Though the detection 
and quantitation of EPO from complex samples is achievable using existing methods, our 
goals were to improve upon these methods in several areas, as outlined below.   
1. Develop a system able to (a) selectively capture, (b) detect, and (c) quantify 
biomolecules from complex biological matrices using SERS.  
2. Complement current methods for biomolecule detection by considering: (a) cost-
effectiveness; (b) analysis time; (c) ease of use; (d) detection limits and; (e) 
portability. 
 
After reviewing the broad array of literature on nanomaterials for biomolecule analysis 
(Chapter 1), the initial approach develops and tests antibody-functionalised hybrid 
nanoparticles to selectively extract EPO, and uses label-free direct SERS to monitor, identify, 
and quantify (Chapter 2). The initial methodology was then modified and adapted to 
aptamer-functionalised nanostructured surfaces for the same model protein, for label-free 
indirect monitoring and quantitation of EPO using SERS (Chapter 3).  
34 
 
  
35 
 
Chapter	2 		
Preface 
In the previous chapter (Chapter 1), the lack of literature on cost-effective and rapid 
selective isolation methods for the label-free SERS detection of biomolecules from complex 
biological matrices was established. Furthermore, existing research into SERS-based 
detection of EPO in complex biological samples is lacking, with no reported Raman spectrum 
of post-separation EPO found in the literature. As a result, the first step was to establish a 
method of selectively extracting EPO from a relevant biological mixture.  
This chapter will focus firstly on the development of hybrid material nanoparticles 
functionalised with antibodies. The use of hybridised materials allows for the combination 
of multiple desirable material properties, whilst antibodies allow for selective capture of a 
target species. Secondly, the chapter will evaluate the use of these developed nanoparticles 
for extraction of erythropoietin from a blood matrix. The medical and anti-doping relevance 
of EPO is well-known, and as EPO is an endocrine hormone, blood is the logical choice of 
test matrix. This will be carried out using label-free SERS as a detection and quantification 
method. The advantages of this are two-fold, with SERS able to provide a spectroscopic 
fingerprint of the EPO analyte, rather than indirect evidence of its presence using a labelling 
molecule, as well as being a highly sensitive detection method.  
This chapter details the synthesis and testing of hybrid nanoparticles, consisting of an 
iron oxide core and gold shell, functionalised with thiol-bound antibody for the specific and 
rapid separation of a target protein, EPO. Label-free SERS methods were used to monitor 
the antibody-antigen binding, followed by release of EPO for direct spectroscopic 
fingerprinting of the purified analyte, and direct spectroscopic quantitation. Our primary 
focus was the successful development and testing of the aforementioned process using EPO 
as a model protein, along with appropriate validation techniques. The overarching design 
goal was to devise a system suitable for point-of-care testing and in-field protein screening. 
The approach methodology is justified briefly below. 
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(i) Hybrid iron oxide/gold coated nanoparticles: provides benefits of gold surface 
for SERS and ease of functionalisation using thiol chemistry whilst retaining 
magnetic properties for rapid separation. 
(ii) Selective extraction: by functionalising the gold surface with target-specific 
antibody and backfilling with a small thiol, biomolecules can be selectively 
captured from a complex matrix.  
(iii) Screening: spectroscopic monitoring of antibody-antigen binding using SERS.  
(iv) Direct detection and quantitation: releasing captured protein from antibody-
antigen complex to obtain purified protein extract, then measure its direct SERS 
fingerprint. This can then be used for label-free quantitation.  
(v) Portability: developed system to be paired with a handheld Raman spectrometer 
to analyse the extracted biomolecules and test the system for in-field use.  
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[2.1] Abstract 
Isolating, purifying, and identifying proteins in complex biological matrices is often 
difficult, time consuming, and unreliable.  Herein we describe a rapid screening technique 
for proteins in biological matrices that combines selective protein isolation with direct 
surface enhanced Raman spectroscopy (SERS) detection. Magnetic core gold nanoparticles 
were synthesised, characterised, and subsequently functionalized with recombinant human 
erythropoietin (rHuEPO)-specific antibody. The functionalized nanoparticles were used to 
capture rHuEPO from horse blood plasma within 15 minutes. The selective binding between 
the protein and the functionalized nanoparticles was monitored by SERS. The purified 
protein was then released from the nanoparticles’ surface and directly spectroscopically 
identified on a commercial nanopillar SERS substrate. ELISA independently confirmed the 
SERS identification and quantified the released rHuEPO. Finally, the direct SERS detection of 
the extracted protein was successfully demonstrated for in-field screening by a handheld 
Raman spectrometer within 1 minute sample measurement time.  
 
 
Scheme 1 - Extraction of target analyte using developed specific extractor nanocomposites and SERS
detection using handheld Raman. 
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[2.3] Background 
The efficient and accurate analysis of biomolecules found in complex biological 
matrices like blood or urine is essential for many applications, including protein 
characterization, clinical diagnostics, and drug dosing protein analysis, but current methods 
are usually expensive and time consuming.[113-116] Simultaneous methods for sample 
separation and detection must exhibit sufficiently high resolution, high sensitivity and wide 
dynamic range to detect low concentrations of proteins.[34, 117, 118]  Ideally, these methods 
should also be easy to perform, rapid, non-toxic, environment-friendly, and cost-effective.  
No current protein detection technique meets all these demands.[34, 117, 118]  Although mass 
spectrometry (MS) is sensitive and accurate for the analysis of proteins,[119, 120] it is relatively 
expensive, requires specialised skills, and cannot be field adapted.   
Enzyme-linked immunosorbent assay (ELISA) is a widely used technique in protein 
analysis. ELISA methods fall in two categories, direct and indirect. The direct methods use 
only one primary antibody while the indirect methods use primary and secondary 
antibodies. Direct ELISA methods have significant disadvantages such as: 1) the antibody’s 
immune-reactivity is adversely affected by labelling with enzymes or tags; 2) labelling the 
used antibody is time-consuming and expensive; 3) there is only a limited choice of antibody 
labels that can be used from one experiment to another; 4) the signal amplification is 
modest. Indirect ELISA methods suffer from other disadvantages such as the long analysis 
time, due to the introduction of extra incubation steps in the procedure, and cross-reactivity 
with the secondary antibody, which result in nonspecific signals.[121] 
Surface-enhanced Raman spectroscopy (SERS), which characterises molecules by 
their vibrational fingerprint, is a rapidly emerging technique for the detection of 
biomolecules.[122, 123]  In SERS, the surface plasmon resonance (SPR) of a nanostructured 
noble metal surface enhances the oscillating electric field of incident light.[124] This near-field 
enhancement increases the Raman signal of analyte molecules that are in close proximity to 
the metal surface by factors as high as 106–108 relative to the unenhanced Raman signal,[124-
126] making it useful for ultra-trace detection and potentially allowing for single-molecule 
detection.[42, 127]   
SERS strategies may be employed to either directly or indirectly detect biomolecules. 
In the direct method, a biological sample is loaded onto a noble metal substrate and directly 
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analysed by SERS to acquire the Raman signature of the biomolecule.[89, 128, 129] SERS 
provides direct structural information about the bound target molecule and identifies 
qualitative differences between similar samples. However, this approach lacks specificity 
and the Raman spectroscopic features other molecules present in a complex biological 
matrix can obscure the Raman characteristics of the target analyte.  For this reason, 
extensive isolation and clean-up procedures are required prior to direct SERS detection.[112] 
By comparison, SERS may indirectly detect biomolecules by attaching a Raman-active dye to 
the metal SERS substrate.[128, 130] The substrate’s surface carrying the Raman dye is then 
pacified with a protective layer (e.g. silica shell) to prevent the non-specific binding of 
potentially interfering biomolecules in a complex biological matrix. Analyte-specific 
recognition molecules, such as antibodies or aptamers, are attached to the SERS substrate 
to provide target specificity.[128] However, indirect SERS detection does not detect the target 
biomolecule itself, but only detects the SERS spectrum of the Raman dye.[112]  Specific 
recognition of the target analyte by the antibody or aptamer must be assumed to occur 
without significant cross reactivity. 
We recently demonstrated a hybrid approach for label-free indirect SERS detection 
of proteins, in which a SERS substrate was functionalized with a protein-specific antibody or 
aptamer for target specificity, but no Raman dye was attached to the SERS substrate.[112, 130] 
Instead, the SERS spectra of surface-bound antibody or aptamer were compared before and 
after the binding of the target protein.  Differences in features between the spectra were 
used to identify the target protein in aqueous and biological samples. 
Erythropoietin (EPO) is a glycoprotein hormone used in the regulation of 
erythropoiesis and is involved as a signalling protein in the production of red blood cells in 
bone marrow.[131] Sports doping with exogenous rHuEPO increases oxygen capacity and 
leads to enhanced aerobic performance by athletes. The short biological half-life of rHuEPO 
makes it only detectable in urine for 3–7 days.[132-134] Recent doping regimens, in which 
micro-doses of rHuEPO (approximately 20–25 IU/kg) are administered to avoid random 
detection by anti-doping authorities, have reduced the rHuEPO detection window to only 
12–18 hours.[135]  The standard protocol currently used to detect rHuEPO doping in 
competitive sports, isoelectric focusing and double blotting,[136] takes several days to 
perform in a laboratory-based environment and requires skilled technicians, complex 
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procedures, and expensive equipment. To detect rHuEPO doping in sports environment, a 
reliable rHuEPO screening technique is required that is both rapid and field adaptable. In 
order to identify rHuEPO in urine and blood, the existing reference techniques attempt 
direct detection of the substance and/or its metabolite in its original biological matrix.[117, 
137]  This requires extensive clean-up procedures to isolate the protein from the biological 
matrix of origin prior to the measurement.  
Here we introduce a modified approach for simplified selective isolation and label-
free direct SERS detection of rHuEPO to demonstrate the utility of this technique for 
detecting biomolecules in complex biological matrices (Scheme 1). We first developed 
magnetic core gold nanoparticles and functionalized their surfaces with rHuEPO-specific 
antibodies to create a rHuEPO-specific recognition layer. The remaining bare gold surface on 
the nanoparticles surface was pacified by backfilling with an alkane thiol to block non-
specific binding of potentially interfering molecules. The functionalized nanoparticles 
selectively captured rHuEPO from spiked horse plasma. The binding event between rHuEPO 
and the functionalized nanoparticles was monitored by SERS.[138] To confirm the selective 
capture of rHuEPO, as well as to directly detect the its Raman fingerprint, the bound rHuEPO 
molecules were released from the extractor nanoparticles, loaded onto a gold-coated silicon 
nanopillar substrate and characterised by SERS.  To cross-validate our methodology, rHuEPO 
that had been captured by our functionalized nanoparticles was screened by an 
independent laboratory using rHuEPO-specific ELISA. Finally, to demonstrate applicability of 
this new method for the in-field rapid screening of rHuEPO, we directly acquired the SERS 
spectrum of the captured and released rHuEPO using a handheld Raman device and 
compared it to a standard rHuEPO SERS spectrum.  
The significant advantages of the protein analysis methodology that we describe 
here include: 1) the rapid and selective isolation of the target proteins directly from a 
complex biological matrix; 2) the ability to monitor the selective antibody-antigen binding 
event by SERS; 3) the ability to directly detect the native protein’s Raman fingerprint by 
SERS; and 4) the applicability of this technique to the rapid detection of proteins in the field. 
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[2.4] Experimental details 
 Chemicals and materials 
Recombinant human erythropoietin international standard (rHuEPO IS, 3rd 
International Reference Preparation) was sourced from the National Institute for Biological 
Standards and Control, UK. 7D3 mouse monoclonal anti-human erythropoietin antibody was 
purchased from MAIIA Diagnostics, Uppsala, Sweden. Gold (III) chloride (HAuCl4), phosphate 
buffered saline, bovine serum albumin, sodium borohydride (NaBH4, 99%), trisodium citrate 
(Na3C6H5O7· 2H2O), ferrous chloride (FeCl2. 4H2O), ferric chloride (FeCl3. 6H2O), nitric acid 
and sodium hydroxide were of analytical grade and purchased from Sigma-Aldrich (USA). 
Gravity flow size-exclusion columns (illustra NAP-5) were obtained from GE Healthcare Life 
Sciences (AU). Deionized water (ultrapure Millipore filtered, 18.2 MΩ.cm@25˚C) was used in 
all preparations. All glassware was cleaned with aqua regia and thoroughly rinsed with 
deionized water prior to use. Quantikine IVD human erythropoietin ELISA kit from R&D 
Systems (USA, catalogue No DEP00) was used for the detection of rHuEPO in horse plasma. 
 Instrumentation 
The iron oxide nanoparticles and the magnetic core gold nanoparticles were 
characterised by transmission electron microscopy (TEM) [JEOLJEM-1400 (JEOL, USA)] and 
UV–visible spectroscopy [Cary 100 spectrophotometer (Agilent Technologies, USA)]. For the 
determination of the iron oxide phase, samples were dried and prepared as a thin film, then 
the X-Ray diffraction patterns were collected using a Philips X'pert wide angle X-Ray 
diffractometer operating in step scan mode, with Co Kα radiation (1.7903 Å). Patterns were 
collected in the range 10 to 80° 2θ with a step size of 0.02° and a rate of 30s per step. The 
XRD patterns were matched with ICSD reference patterns using the software package 
HighScore Plus. 
Raman spectra were collected on the Renishaw inVia Raman Microscope using an 
excitation wavelength of 785 nm and 0.5% of maximum (450mW) laser power. Spectra were 
collected by a 50x objective lens over a wavelength range from 300 cm-1 to 1800 cm-1 using 
10 accumulations (1 second exposure time per accumulation). At least 30 spots, on various 
locations of the SERS substrate, were screened per each submitted sample. 
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For SERS measurement using the handheld IDRaman Mini, the sample was screened 
in the Raster Orbital Scanning (ROS) mode using 785 nm excitation wavelength and 40 
accumulations per minute per sample.[139] 
 Synthesis of iron oxide nanoparticles 
To develop the magnetic iron oxide cores, Fe3O4 nanoparticles were first prepared by 
precipitation, and then chemically oxidized to γ-Fe2O3.[107, 140] Briefly, FeCl3.6H2O (10 mmol) 
and FeCl2.4H2O (5 mmol) were dissolved in dilute hydrochloric acid solution (12.5 mL, 0.36 
M) with magnetic stirring. The developed clear yellow solution was then added dropwise to 
NaOH solution (125 mL, 1.5 M) with vigorous stirring where a black precipitate was 
immediately formed. The resulting mixture was stirred for 10 minutes after complete 
addition. The formed precipitate was then collected using strong permanent magnet. To 
neutralize the pH of the precipitate, it was rinsed with dilute hydrochloric acid solution (250 
mL total, 0.01 M). Finally, the precipitate was washed several times with deionized water. 
The washed precipitate was then re-suspended in dilute nitric acid solution (125 mL, 0.01 
M), boiled to reflux for one hour, then cooled to room temperature. The resulting iron oxide 
nanoparticles were collected using a magnet and rinsed several times with deionized water 
to neutralize the medium.  The clean brown-coloured product was resuspended in 50 mL of 
deionized water, and the concentration was determined gravimetrically to be 0.177 M. 
 Development of magnetic core gold nanoparticles 
To develop a gold shell onto the iron oxide nanoparticle surface, a method described 
by Tamer et. al[141] was adopted with modifications. 0.6 mL of the iron oxide nanoparticle 
colloid (0.177 M) was transferred into a 100 mL volumetric flask and diluted with deionized 
water. 19 mL of the resulting solution was transferred to another round-bottomed flask. 
HAuCl4 (0.5 mL, 1%) was then added and the resulting mixture diluted to 100 mL with 
deionized water. To reduce gold atoms onto the iron oxide nanoparticles’ surface, freshly 
prepared NaBH4 solution (0.2 mL, 0.05 M) was added to the mixture, followed by 5 
successive additions of 0.1 mL NaBH4 (0.05 M). The mixture was vigorously swirled for 10 
minutes after each addition. The mixture was then heated to boil and 3 mL of sodium citrate 
solution (0.1 M) was added dropwise to produce a pink coloured colloid. The formed 
magnetic core gold nanoparticles were removed from the reaction mixture using a magnet. 
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The nanoparticles were then washed several times with DI water and finally resuspended in 
4 mL of DI water.  
 Development of antibody-functionalized magnetic core gold 
nanoparticles 
To attach the 7D3 anti rHuEPO antibodies to the gold surface of the magnetic core 
gold nanoparticles, cysteamine was used as a linker. The amine group of cysteamine was 
utilized to form amide bond with the C-terminus of the antibody structure.[142] For this 
purpose, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide solution (EDAC, 0.2 M) and N-
hydroxysuccinimide solution (NHS, 0.1 M) were prepared in PBS (pH 7.4) and used to 
activate the -COOH groups of the 7D3 anti-rHuEPO antibody.[142] 50 µL of both EDAC and 
NHS solutions were added to a LoBind vial and vortexed for 15 minutes. 100 µL of aqueous 
cysteamine (3x10-5 M) was then added to the vial and mixed for another 15 minutes. 50 µL 
of the 7D3 anti-rHuEPO antibody (2x10-5 M in PBS, pH 7.4) was then added to the mixture in 
ten equal volumes with 2 minutes vortex between additions. After complete mixing, the 
solution was allowed to stand for 5 hours under dark conditions at 4˚C. After this time, the 
reaction mixture was purified using a gravity flow size-exclusion column to obtain the 
cysteamine-bound 7D3 antibody.  
To attach the cysteamine-bound 7D3 antibody to the magnetic core gold 
nanoparticles, 100 µL of the nanoparticles were mixed with 50 µL of the antibody in a 
LoBind Eppendorf vial and left to form Au-S bonds between the thiol (-SH) group of 
cysteamine-bound antibodies and the gold surface of the nanoparticles overnight at 4˚C. To 
prevent non-specific binding of interfering analytes and enhance the selectivity of the 
functionalized nanoparticles towards the target protein, any remaining bare sites (i.e. gold 
surface areas that were not occupied by the antibodies) were backfilled by adding 15 µL of 
1-butanethiol (1x10-6 M in PBS, pH 7.4) and allowing the mixture to stand for at 1 hour.[143, 
144] The backfilled functionalized magnetic core gold nanoparticles were then separated 
using a magnet, resuspended in 100 µL PBS (pH 7.4), and stored in a refrigerator at 4˚C.  
 Selective isolation and SERS monitoring of rHuEPO binding to 
functionalized nanoparticles 
The backfilled functionalized nanoparticles were used to selectively capture rHuEPO 
from aqueous solution. An aqueous standard of rHuEPO (1.1 x10-8 M in PBS buffer, pH 7.4) 
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was added to the functionalized nanoparticle colloid in the ratio of 1:10 v/v. The mixture 
was left to stand for 15 minutes to complete binding between the antibody and rHuEPO. 
The protein-bearing functionalized nanoparticles were then collected using a magnet and 
washed several times with PBS buffer (pH 7.4) to remove unbound protein. The protein-
bearing functionalized nanoparticles were then screened using SERS and the acquired 
spectrum compared to that of the functionalized nanoparticles prior to their interaction 
with the rHuEPO. 
For the isolation of rHuEPO from a biological matrix, rHuEPO spiked horse plasma 
was mixed with the backfilled functionalized nanoparticles and PBS buffer (pH 7.4) in the 
ratio of 1: 5: 50 respectively, to a total volume of 100 μL. The final concentration of rHuEPO 
in the mixture was 1 nM. The mixture was then left to stand for 15 minutes to the complete 
binding between the nanoparticles and rHuEPO. The nanoparticles were then magnetically 
removed from the matrix and rinsed several times with PBS buffer (pH 7.4) to remove any 
unbound proteins.  
Blank horse plasma samples were donated by Biological Research Unit, Racing 
Analytical Services Ltd, Melbourne. The samples were collected under the Melbourne lab 
protocols and ethical clearances, arrangements and protocols are all maintained by this lab. 
The samples were also shipped under their lab protocols for shipping biological specimens. 
The samples were received at QUT and used as a matrix for Raman testing. 
 Direct SERS detection and ELISA assay of extracted rHuEPO from horse 
plasma 
For the direct SERS detection of rHuEPO from spiked horse plasma, the protein-
bearing functionalized nanoparticles were reconstituted in 100 μL of N-acetyl glucosamine 
buffer to release the captured protein.[145] The released protein solution was then loaded 
onto a preconditioned gravity flow size exclusion column for 5 minutes to remove the 
buffer. The protein was eluted off the column using 500 μL of deionized water. 10 µL of the 
clean rHuEPO solution was then loaded onto gold-coated silicon nanopillars SERS 
substrate[146, 147] and directly screened by SERS for 1 minute using the Renishaw inVia Raman 
Microscope as well as a handheld Raman spectrometer (ID Raman, ocean optics, USA).  
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For cross validation of the SERS measurements, aliquots of the extracted rHuEPO 
were submitted to independent screening by Solid Phase Sandwich ELISA[148] at the research 
unit, Racing Analytical Services Ltd, Melbourne, Australia.  
[2.5] Results 
 Synthesis and characterization of magnetic core gold nanoparticles 
The attraction towards magnetic core gold nanoparticle synthesis is due to their 
novel properties and potential applications in various fields such as cellular 
hyperthermia,[149] magnetic resonance imaging,[150] drug and gene delivery,[78] as well as 
biotechnology.[151] In these applications, the iron oxide core performs as a giant 
paramagnetic atom with a fast response to the applied magnetic field especially when the 
size of the core is between 5 and 20 nm.[152]  Gold is chemically stable, biocompatible, and 
has excellent plasmonic properties for SERS.[153] Due to the surface chemistry of gold, the 
development of gold shells onto the iron oxide nanoparticles surface facilitates the 
functionalization of the nanoparticles with EPO-specific antibody[149] as well as enhances the 
stability of the magnetic core of the nanoparticles.[107, 140] 
In this work, γ-Fe2O3 nanoparticles were synthesised for the deposition of a gold 
shell.[154, 155] The synthesized nanoparticles were spherical in shape with a mean size 
distribution of 10±2 nm as characterized by TEM (Figure 12a). The phase of the γ-Fe2O3 
nanoparticles was confirmed by X-ray diffraction (Figure 13). Both the magnetite and 
maghemite phases have the same spinel structure as well as very similar lattice parameters. 
The peaks at diffraction angles (2θ) of 35.3°, 41.7°, 50.8,° 67.7°, and 74.9° degrees indicate 
that the pattern could be indexed to a cubic structure of either magnetite or maghemite. 
The peaks at 24.7° and 21.3° also suggest the presence of both magnetite and maghemite 
phases of the iron oxide. However, the high intensity of the peak at 41.7 indicates that the 
iron oxide nanoparticles exist predominantly in the maghemite phase.[152]  
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Figure 12 - TEM micrograph of (a) iron oxide nanoparticles and (b) iron core gold coated nanoparticles. 
 
 
Figure 13 - XRD pattern of iron oxide nanoparticles. 
 
To develop a gold shell onto the surface of the magnetic nanoparticles, iterative 
reduction of HAuCl4 was carried out using sodium borohydride to initially nucleate gold onto 
the iron oxide nanoparticles surface. Subsequent sodium citrate reduction of Au3+ ions to Au 
expanded the nucleated gold into a shell around the magnetic core. The resulting magnetic 
core gold nanoparticles were spherical with an average size of 15±6 nm as indicated by TEM 
(Figure 12b). The plasmonic properties of the magnetic core gold nanoparticles were 
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confirmed by a characteristic plasmon band at 530 nm observed by UV–visible spectroscopy 
(Figure 14).  
 
Figure 14 - UV-Vis spectrum of magnetic core gold nanoparticles. 
 
 Selective isolation and SERS monitoring of rHuEPO binding to AuMNPs 
The magnetic core gold nanoparticles were then functionalized with 7D3 anti-
rHuEPO antibodies and used for the selective isolation of rHuEPO. Functionalizing a gold 
nanoparticle surface with antibodies has been previously described,[142] where cysteamine 
was used to link an active carboxylic acid terminus, of Aflatoxin B1 antibody (via an amide 
bond) to the gold surface. Unfortunately, cysteamine on a gold surface may adopt a gauche 
configuration in which the cysteamine molecule binds to the gold nanoparticles from both 
its thiol and amine ends.[156] In this conformation, the amine group of cysteamine would not 
be available to bind the antibody.[66] To maximize the number of antibody molecules bound 
to the surface of gold nanoparticles and enhance the capacity of the nanoparticles to bind 
the target protein, the amide bond between cysteamine and the active 7D3 antibody 
carboxylate groups was formed in solution. Next, the cysteamine-bound antibody was 
attached to the gold surface of the magnetic core nanoparticles via an Au-S bond. The 
unfunctionalized areas of the nanoparticles’ surface were backfilled with 1-butanethiol to 
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prevent non-specific binding of interfering analytes and ensure the selectivity of the 
nanoparticles towards rHuEPO.  
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[2.6] Discussion 
 Surface-enhanced Raman spectra 
Once functionalized and blocked, the magnetic core gold nanoparticles were then 
used to isolate rHuEPO from an aqueous solution. The binding of rHuEPO to the 
functionalized nanoparticles was directly monitored by comparing the SERS spectra of the 
nanoparticles before and after interaction with the protein. The SERS spectrum of the 
functionalized nanoparticles before interaction with the protein is depicted in Figure 15a. 
The Raman bands at 565 cm-1, 752 cm-1 and 1549 cm-1 are characteristic of the antibody 
tryptophan residues.[154, 155, 157-159] The 960 cm-1 band represents a C-C stretching vibrational 
mode[154, 158] and the 1062 cm-1 band may be attributed to a C–N stretching vibrational 
mode.[154, 157, 160] The characteristic band at 1203cm-1 arose from the phenylalanine and 
tyrosine residues in the antibody.[154, 157, 160] The 1425 cm-1 band may be attributed to the 
tyrosine residues and the CH vibrations of tryptophan indole rings within the antibody 
skeleton.[154, 158] Finally the band at 1584 cm-1 may be attributed to Tryptophan, Tyrosine, 
Phenylalanine residues[157, 159, 161]  while the band at 1611 cm-1 is due to Phenylalanine and 
amide I (α helix) vibration modes.[154, 155, 162]  
 
Figure 15 - SERS spectrum of antibody-functionalized gold nanoparticles a) before and b) after binding with 
rHuEPO. 
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The SERS spectrum of the functionalized nanoparticles after interaction with rHuEPO 
(Figure 15b) showed significant changes in spectral features that may be attributed to the 
binding event between the 7D3 antibody and the target protein.[161] The characteristic 
tryptophan Raman bands now appear at 786 cm-1, 871 cm-1 and 1584 cm-1.[154] The band at 
1437 cm-1 may be attributed to CH2 scissoring vibration mode.[154, 158, 159, 162] The band at 
1028 cm-1 may be attributed to the in-plane ring CH deformation of the phenylalanine 
residues of the protein.[154] The low intensity of this band suggests that the phenyl ring 
approaches the gold surface of the nanoparticles but is not directly adsorbed onto the 
surface. Thus, the phenyl ring–nanoparticles interaction is weak.[154] The absence of the 
phenyl ring breathing vibration at 1002 cm-1 also suggests that the protein is not directly 
adsorbed onto the gold nanoparticles and the rHuEPO phenylalanine residues reside at a 
distance from the substrate’s gold surface.[154]  
The asymmetric vibrations (Cα CN and NH3+ deformation) of the CNH2 groups within 
the protein structure are expressed by the band at 1132 cm-1.[154, 157, 159, 160] The amide III 
vibrations of the complex formed between the antibody and rHuEPO are indicated by two 
Raman bands at 1225 cm-1 and 1248 cm-1.[154, 155, 159, 162] The weak band at 1523 cm-1 can be 
attributed to the amide II vibration of antibody-rHuEPO complex.[154, 157] Despite the fact 
that the amide II band of proteins is Raman inactive, it may become enhanced when the 
protein structure is immobilized in a close proximity to the surface of a noble metal.[154] 
Finally, the amide I vibration of the antibody-EPO complex now appears at 1642 cm-1.[154, 155, 
157-159, 162] The spectral differences between the free functionalized nanoparticles and the 
rHuEPO-bound nanoparticles were used to monitor the binding event between the protein 
and the functionalized nanoparticles and, in effect, the selective isolation of the target 
protein from the sample matrix. This process is simple and does not require complex 
pretreatment and preconcentration procedures as in the case of other techniques, such as 
HPLC-MS.   
 Direct SERS detection of rHuEPO 
To confirm the selective isolation of rHuEPO and to demonstrate the direct detection 
of the extracted protein by SERS, we used the functionalized nanoparticles to extract the 
protein from spiked horse plasma. The captured protein was then released from the 
nanoparticles’ surface using a releasing buffer.[163] The purified protein extract was then 
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directly screened by SERS. The SERS spectra of the extracted protein and rHuEPO standard 
are depicted in Figure 16 and show significant correlation. The SERS spectrum of the 
extracted rHuEPO (Figure 16b) shows the characteristic Raman bands of a protein (Table 2).  
 
Figure 16 - SERS spectrum of (a) rHuEPO standard and (b) rHuEPO extracted from horse plasma. 
Measurements were carried out on gold-coated silicon nanopillars SERS substrate and using the inVia 
Renishaw Raman spectrometer. 
Table 2 - Assignments of Raman bands in the SERS Spectra (Figure 16b) of rHuEPO extracted from spiked 
horse plasma. 
RAMAN SHIFT (CM− 1) BAND ASSIGNMENT REFERENCE 
1001 Benzene ring breathing of phenylalanine [155]
1149 ring stretch/νas(CαCN) [157, 162]
1176 Phenylalanine, Tyrosine [154, 159, 160]
1214 Phenylalanine [154, 161]
1245 Amide III [154, 162]
1286 Amide III [154]
1347 Tryptophan [154]
1380 νas(COO−) [154, 157]
1468 CH2 (scissoring) [155, 157, 162]
1507 Phenylalanine, Histidine, Tryptophan [154, 159]
1534 Amide II [157]
1587 Tryptophan, Tyrosine, Phenylalanine [157, 160, 161]
1611 Amide I (α helix), Phenylalanine [154, 155, 162]
 
For cross-validation purposes, an aliquot of the post-extraction product was also 
screened by independent analytical services laboratory using ELISA. The ELISA screening 
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confirmed that rHuEPO was present in this protein extract at concentration of 72 mIU/mL 
(553.7 pg/mL).   
 Direct SERS detection of rHuEPO by handheld Raman spectrometer 
In order to demonstrate our methodology for the in-field screening of rHuEPO in 
biological matrices, we loaded the protein extract (from horse plasma) onto a commercial 
SERS substrate and used a handheld Raman spectrometer for the direct SERS detection of 
rHuEPO. The SERS spectra of the extracted protein and rHuEPO standard are depicted in 
Figure 17. The match between the two spectra is obvious. The measurements were carried 
out in the Raster Orbital Scanning (ROS) mode and took only one minute per sample to 
acquire the SERS spectrum. This sample scanning mode allows for scanning of a large area of 
the sample with a tightly focused laser beam. The ability to screen a large area of the 
sample increases the number of Raman-active molecules being probed by the excitation 
laser beam and, therefore, provides higher sensitivity data. The quality and the notable 
match in the SERS spectra (Figure 17) may be attributed to the ability of the ROS screening 
mode to acquire an average SERS spectrum from the entire sample load on the SERS 
substrate.[150, 164]  
56 
 
 
Figure 17 - SERS spectrum of a) rHuEPO standard and b) rHuEPO extracted from horse plasma. 
Measurements were carried out on using handheld Raman spectrometer (1 minute measurement time per 
sample). Spectra were collected using 785 nm excitation wavelength and a single 40 second accumulation in 
Raster Orbital Scanning (ROS) mode.  
In order to demonstrate the capacity of our protein analysis method, towards SERS 
quantification of rHuEPO, various concentrations of in the range of 50nM – 5 pM aqueous 
rHuEPO were employed. To each concentration of rHuEPO, a fresh substrate was used for 
the SERS quantification by the handheld Raman spectrometer. The laser power at the 
sample was 50 mW and a 5 second accumulation was carried out for each concentration. 
The band at 1551 cm-1 was used a as a reference band for rHuEPO quantification. The SERS 
signals were found to decrease with decreasing concentration as indicated by Figure 18a.  A 
linear relationship was obtained between the SERS signal intensity at 1551 cm−1 and the 
corresponding rHuEPO log concentration plot is depicted in Figure 18b. As indicated by 
Figure 7b, close correlation (r2 = 0.995) was found over the concentration range of 50 nM to 
5 pM rHuEPO. The minimum limit of detection was estimated mathematically using the 
regression equation in Figure 18b and found to be 1 pM.    
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Figure 18 – (a) SERS spectra, at 1551 cm-1, of rHuEPO in the concentration range 50 nM to 5 pM and (b) Plot 
demonstrating the linear relationship between log concentration of rHuEPO and SERS intensity at 1551 cm-1. 
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[2.7] Conclusion 
In conclusion, we demonstrated the selective isolation and direct SERS detection of 
rHuEPO using antibody-functionalized nanoparticles and SERS. The changes in the SERS 
spectrum of the antibody-functionalized nanoparticles after their binding to a protein allow 
for monitoring the binding event by SERS. The direct SERS detection of extracted rHuEPO 
from a biological matrix is demonstrated for the first time. The SERS detection of the protein 
was supported by ELISA, which confirmed and quantified the rHuEPO in the protein extract. 
The iron core of the gold-coated nanoparticle plays a key role in the magnetically induced 
separation of rHuEPO from the matrix. However it does not play any operational role in the 
detection process of rHuEPO.  The burden of detection rests entirely on the plasmonic 
response of the Au shell and thus the detection mechanism is independent of whether the 
core is magnetic or not. Finally, the methodology was successfully utilized for the rapid in-
field screening of rHuEPO within a biological matrix using a commercial SERS substrate and 
handheld Raman device. This study demonstrates a proof of concept for the combined 
selective isolation and in-field direct SERS detection of proteins in complex matrices. Our 
future work is directed towards reproducible direct SERS quantification of ultra-trace 
amounts of proteins in biological matrices using the demonstrated methodology and 
handheld spectrometer. 
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Chapter	3 		
Preface 
In the previous chapter (Chapter 2), iron/gold core/shell hybrid nanoparticles 
functionalised with anti-EPO antibodies were demonstrated to be capable of rapid and 
selective capture and direct spectroscopic identification rHuEPO from a blood matrix. 
Furthermore, the SERS spectrum could be used to quantify rHuEPO at nanomolar to 
picomolar concentrations.  
Areas of the previous work were investigated for potential improvement. Firstly, the 
nature of nanoparticle-based SERS screening, where high enhancement regions known as 
“hot spots” are dependent on the distribution of the nanoparticles could be better 
controlled for improved screening signal homogeneity. Secondly, the use of aptamers as 
alternatives to antibodies for selective capturing was investigated to try to reduce 
production costs and improve shelf-life.  
This chapter details the development of aptamer-functionalised nanostructured 
surfaces for the selective extraction of EPO, followed by SERS identification and 
quantitation. The issue of nanoparticle distribution was addressed by electrochemically 
reducing gold to form spherical gold nanoparticles (AuNS) over a polished gold substrate 
(pAu). This method was selected to deposit densely packed nanospheres across the surface 
in a highly controlled fashion. The pAu/AuNS surface could then be functionalised with 
aptamers to selectively capture a target species, rHuEPO, prior to SERS analysis. This 
method analyses species captured on the surface rather than the pure (captured and 
released) analyte. The explored methodology is similar to that of the previous chapter 
(Chapter 2 Preface), with appropriate modifications shown below. 
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(i) pAu/AuNS synthesis: electrochemical deposition of gold nanospheres allows for 
controlled distribution, as well as enabling SERS capabilities and ease of surface 
functionalisation using thiol chemistry. 
(ii) Reproducibility of SERS spectra: analyse AuNS distribution and packing density 
across pAu to assess SERS enhancement and signal homogeneity. 
(iii) Selective extraction: by functionalising the gold surface with target-specific 
aptamer and backfilling with a small thiol molecule, target biomolecules can be 
selectively and rapidly captured onto the surface from a complex matrix. 
(iv) Screening and quantitation: monitoring of aptamer-antigen binding using SERS 
to detect presence of target biomolecule. Quantify target biomolecule using 
label-free SERS.  
(v) Portability: analyse the captured biomolecule with a handheld Raman 
spectrometer to test the system for in-field use.  
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[3.1] Abstract 
Erythropoietin (EPO), a glycoprotein hormone of ∼34 kDa, is an important 
hematopoietic growth factor, mainly produced in the kidney and controls the number of red 
blood cells circulating in the blood stream. Sensitive and rapid recombinant human EPO 
(rHuEPO) detection tools that improve on the current laborious EPO detection techniques 
are in high demand for both clinical and sports industry. A sensitive aptamer-functionalized 
biosensor (aptasensor) has been developed by controlled growth of gold nanostructures 
(AuNS) over a gold substrate (pAu/AuNS). The aptasensor selectively binds to recombinant 
human erythropoietin (rHuEPO) and, therefore, was used to extract and detect the drug 
from horse plasma by surface enhanced Raman spectroscopy (SERS). Due to the nanogap 
separation between the nanostructures, the high population and distribution of hot spots 
on the pAu/AuNS substrate surface, strong signal enhancement was acquired. By using wide 
area illumination (WAI) setting for the Raman detection, a low RSD of 4.92% over 150 SERS 
measurements was achieved. The significant reproducibility of the new biosensor addresses 
the serious problem of SERS signal inconsistency that hampers the use of the technique in 
the field. The wide area illumination setting is compatible with handheld Raman devices. 
Therefore, the new aptasensor can be used for the selective extraction of rHuEPO from 
biological fluids and subsequently screened with handheld Raman spectrometer for SERS 
based in-field protein detection.  
 
[3.2] Keywords 
Aptamer-functionalized biosensor (aptasensor), nanosensor, homogenous SERS, wide 
area illumination, erythropoietin (EPO), horse plasma 
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[3.3] Background 
Erythropoietin (EPO), a glycoprotein hormone of ∼34 kDa, is an important 
hematopoietic growth factor, mainly produced in the kidney and controls the number of red 
blood cells circulating in the blood stream.[165] After the establishment of human EPO gene 
sequence,[166] recombinant human EPO (rHuEPO), a structural and bio-active analogue of 
human EPO, has been produced as a pharmaceutical to treat patients suffering from 
anaemia symptoms associated with various disorders such as cancer.[167] rHuEPO has also 
been used by athletes as a doping agent in endurance sports to enhance their 
performance.[168] This prompted World Anti-Doping Agency (WADA) to ban the use of the 
drug in sports activities.[165] In addition to its chief function in promoting erythropoiesis, it 
was recently indicated that EPO levels in cancer patients, especially when receiving 
chemotherapy, may significantly affect the growth and progression of malignant 
tumours.[169, 170] Thus, sensitive and rapid rHuEPO detection tools are in high demand for 
both clinical and sports industry.[112] 
In recent years, SERS has emerged as an ultra-sensitive analytical tool.[66, 171, 172] The 
two important features for real world applications of SERS are the homogeneity of the SERS 
substrate and selectivity towards target.[173] Vast numbers of SERS active surfaces 
comprising various roughened metallic surfaces and noble metal nanostructures have been 
produced. However, the majority of surfaces failed to produce a homogeneous SERS signal. 
Conversely, very few substrates which are promising to deliver homogeneous and 
reproducible signal are expensive.[174] Therefore, there is a high demand for cheap, 
homogeneous and reproducible SERS substrates. In principle, the basic requirement for a 
homogeneous and sensitive SERS substrate is defect-free arrangement of metal 
nanoparticles or nanostructures within nanometer scale inter-particle distance.[175]  
Electrodeposition of metal nanostructures is one of the simple, cost effective and 
efficient approaches that realize the defect-free packing of nanostructures over a wide 
area.[176] To enhance the selectivity within SERS, recognition molecules that specifically bind 
to targets can be immobilized on the SERS substrate. However, the size and length of the 
recognition molecule should not be very large otherwise the SERS effect may completely 
diminish due to the long distance between the captured protein and the plasmonic surface. 
In other words, the binding receptor should not be far away from the surface as SERS signal 
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exponentially decreases with respect to the increase in distance between the surface and 
analyte.  
Antibodies are frequently used as recognition molecules for detecting proteins. 
However, antibodies usually have large size that constitutes a serious hurdle to the label-
free SERS detection of proteins.[112] Aptamers are now widely emerging as better choice 
over antibodies.[177] Aptamers are of much smaller size than antibodies and also well-known 
for their high selectivity, binding affinity, easy and quick production, stability and cost-
effectiveness.[178] Moreover, aptamers can bend and orient themselves close to the surface 
of the SERS substrate after binding with the target protein.[179] This orientation would lead 
to high intensity SERS signal due to short distance between the captured target and SERS 
surface. Thus, this article presents a homogeneous and sensitive aptamer-functionalized 
nanosensor for the rapid reproducible and label-free SERS detection of rHuEPO in biological 
fluids. 
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[3.4] Experimental details 
 Chemicals and materials 
Hydrogen tetrachloroaurate (HAuCl4.4H2O) and 6-mercaptohexanol were purchased 
from Sigma Aldrich (USA). The recombinant human erythropoietin (rHuEPO) specific 
aptamer sequence (5′ -HO-S-S-(CH2)6-TTGAAAGGTCTGTTTTTGGGGTTGGTTTGGGTCAA-
3')[180, 181] was synthesized by FRIZ Biochem (Neuried, Germany). Tris(2-
carboxyethyl)phosphine (TCEP) was purchased from Pierce. All other chemicals were of 
Analytical grade. All dilutions were made using deionised water (18.2 MΩ.cm) from a 
Millipore water purification system. Commercial SERS substrates (Au/Si SERStrate) were 
purchased from Silmeco, Denmark. Polycrystalline gold discs (Au) having a geometric area of 
0.502 cm2 and platinum wire (A & E Metals, Australia) were respectively, used as working 
and counter electrode. Dry leakless electrode (DRIREF-2, World Precision Instruments, USA) 
was used as a reference electrode. Polishing slurries and pads (Microcloth®) were purchased 
from Buehler, Germany.   
 Instrumentation 
All electrochemical experiments were carried out in Autolab PGSTAT204 potentiostat 
with a custom-made three-electrode cell setup. All Raman measurements were performed 
using the Renishaw InVia Raman microscope equipped with 785 nm laser line as excitation 
source. Spectra were collected using a 50× and 5× objective lens over a wavelength range 
from 500 cm-1 to 2000 cm-1 using a laser power of 1 mW for 10s (3 accumulations). For each 
Aptamer and rHuEPO spectrum, 10 spectra were randomly recorded over the entire surface 
and averaged. SEM measurements were performed using Zeiss Sigma VP Field Emission 
Scanning Electron Microscope with an accelerating voltage of 5 kV under high vacuum. 
 SERS substrate preparation 
Au disc electrodes were manually mirror-polished with alumina slurries of 
sequentially decreasing particle sizes (0.5 µm, 0.05 µm and 0.02 µm). After each step of 
polishing, the electrodes were immersed in Millipore water and subsequently sonicated in 
an aqueous ultrasonic bath for 15 minutes in order to remove the physically adsorbed 
alumina particles from the electrode surface. Prior to the deposition of gold nanostructures, 
the Au discs were cleaned by immersing into piranha solution for 10 min (3:1, 98% H2SO4 / 
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30% H2O2) and subsequent thorough washing with copious amount of Millipore water. 
Warning: piranha solution is very corrosive and must be handled with extreme caution; it 
reacts violently with organic materials and should not be stored in tightly closed vessels. 
Nanostructured SERS substrate was prepared by potentiostatic deposition of AuNS 
over flat Au surface (pAu/AuNS). The three-electrode electrochemical cell was filled with the 
solution of 4 mM HAuCl4 in 0.1 M HClO4 and subsequently purged with high pure argon gas 
for 30 min to remove oxygen from solution. A potential of -80 mV was applied for 400 s and 
then the electrode was removed from the solution and subsequently washed with Millipore 
water to remove other ions from the surface. The electrode was then dried under a stream 
of nitrogen gas and used as a SERS substrate. 
 Fabrication of aptasensor and rHuEPO capture 
The aptamers were received in lyophilized form and dissolved in selection buffer (20 
mM Tris-HCl, 140 mM NaCl, 5 mM MgCl2 and 5 mM KCl at pH 7.5) to have a stock 
concentration of 100 µM. Prior to fabricate the aptamer over pAu/AuNS surface, 100 µL of 
0.2 µM aptamer was pre-treated with 100 fold excess of tris(2-carboxyethyl)phosphine 
(TCEP) for 1 h at room temperature to reduce the disulfide bond of the aptamer. The 
pAu/AuNS substrate was then incubated in Aptamer-TCEP mixture for overnight at room 
temperature. Followed by the substrate was washed with selection buffer and copious 
amount of Millipore water to remove the unbounded aptamer from the surface. The surface 
was then dried in a gentle stream of argon and immediately transferred into 2 mM 6-
mercaptohexanol (6-MH) in selection buffer and allowed to stand for 3 h. Subsequently, the 
substrate was washed with selection buffer and Millipore water to remove all the 
unbounded 6-MH from the pAu/AuNS surface. Now the aptasensor (pAu/AuNS/Apt) is ready 
to capture rHuEPO. The sensor is then incubated into 1 nM rHuEPO in Tris buffer (pH 7.5) for 
1 h and subsequently washed in Millipore water to remove the free rHuEPO from the sensor 
surface. The aptasensor binding to rHuEPO ((pAu/AuNS/Apt/rHuEPO) was then dried in 
gentle flow of argon prior to SERS measurements. 
 Horse Serum Experiment 
Blank horse plasma samples were donated by Dr. Rohan Steel, Project Leader, 
Biological Research Unit, Racing Analytical Services Ltd, Melbourne. The samples were 
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collected under the Melbourne lab protocols and ethical clearances, arrangements and 
protocols are all maintained by this lab. The samples were also shipped under their lab 
protocols for shipping biological specimens. The samples were received at QUT and used as 
matrix for Raman testing. This did not require PC2 lab at QUT. 
rHuEPO was spiked into the horse serum to obtain a final concentration of 1 nM 
rHuEPO. The aptasensor was then incubated in the rHuEPO spiked horse serum for 1 h and 
subsequently washed to copious amount of water to remove the biological matrix and 
unbounded rHuEPO from the sensor surface. Finally, the substrate was dried in gently flow 
of argon and used for SERS measurements.    
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Figure 19 - SEM images of pAu/AuNS surface under different magnifications.
[3.5] Results and discussion 
 Characterization of SERS substrate 
We optimized gold chloride concentration, electrolyte, applied potential and time to 
have a closely packed single layer of AuNS within nanometer scale inter-particle distance. 
Figure 19 shows the SEM pictures of pAu/AuNS surface. The SEM image under wider 
magnification (Figure 19A) illustrates that the deposition of AuNS is virtually uniform over 
the entire surface.  
Even at a 100 micron field of view, the particle coverage was uniform and defect free (Figure 
20). Similar SEM images were obtained over the entire 8 mm diameter pAu/AuNS disc 
surface which clearly reveals that the electrodeposition method produced homogeneous 
AuNS over the entire surface. Although the sizes of AuNS ranged between 10-100 nm 
(Figure 19B), the uniform close packing of AuNS in single layer lead to homogeneous SERS 
signal for a focused micron-scale laser spot[173] (vide infra). Polished Au was chosen as the 
underlying support since it produces more AuNS particle initiation spots during 
electrodeposition in contrast to glassy carbon or indium tin oxide surfaces.[176] As a result, 
high density of small-sized and closely packed AuNS was produced and led to enormous 
SERS enhancement. Furthermore, a possible coupling between the propagating surface 
plasmon polariton (SPP) of the underlying polished Au surface and surface plasmon 
resonance (SPR) of the AuNS[176, 182] may lead to additional SERS enhancement.  
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 Reproducibility of SERS spectra 
In order to test the homogeneity of the substrate and the reproducibility of the SERS 
signal from various locations on the sensor, we used 2-quinolinethiol (2-QT) as a probe 
molecule due to its large Raman scattering cross-section. Figure 21 depicts the SERS 
spectrum of the self-assembled monolayer of 2-QT over pAu/AuNS substrate.  
 
 
Figure 20 - SEM images of pAu/AuNS surface under wider magnification.
Figure 21 - SERS spectrum 2-QT monolayer on pAu/AuNS surface.
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The intense band @ 1371 cm-1, corresponding to the aromatic ring stretching, was used to 
calculate the relative standard deviation (RSD) of the SERS signal intensity from various 
surface locations. For comparison purposes, we carried out the SERS measurements using 
used 5× (spot diameter = 3.99 µm; illuminated area = 12.56 µ2 and working distance = 14 
mm) and 50x (spot diameter = 0.64 µm; illuminated area = 0.32 µ2 and working distance = 
0.37 mm) objectives respectively. When the laser beam is focused using the 50× objective, 
the RSD of the SERS signal @ 1371 cm-1 (150 measurements from various surface spots, 
Figure 22A) was found to be 8.74%. However, the RSD reduces to 4.92% when using the 5× 
objective (Figure 22B). This decrease in RSD with increase in laser focusing area (5× 
objective has 39.25 times higher illumination area than 50× objective) is rational as the 
acquired SERS signal is highly averaged when increasing the focusing area.  
 
Using a 5× objective to focus the laser beam onto the pAu/AuNS substrate creates a wide 
area illumination (WAI) setting which allows for an increased area of the pAu/AuNS surface 
to be probed when compared to the area probed by the 50x objective. The increase in the 
area probed by the laser excitation beam contributes to the reproducibility of the SERS 
signal.[183, 184] This is confirmed by the low RSD of 4.92% obtained when using the 5x 
objective. In other words, the wide area illumination setting allows for averaging the SERS 
signal from a large surface area of the aptasensor and hence the low RSD of the SERS 
measurements. Also the homogeneity of the particle coverage and packing leads to 
homogeneous distribution of the hot spots to give reproducible SERS signals despite the 
polydispersity (10-100 nm) of AuNS. 
Figure 22 - A series of SERS spectra of 2-QT randomly collected over the entire 8 mm diameter pAu/AuNS
disc using (A) 50x objective with a laser focusing area of 0.32 µ2 and (B) 5x objective with a laser focusing
area of 12.56 µ2. 
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 Selective extraction and SERS investigation of rHuEPO in aqueous 
medium 
The developed pAu/AuNS substrate was then functionalized with EPO-specific aptamer and 
the remaining bare sites on the surface backfilled with 6-mercapto hexanol (see 
supplementary materials) to create the aptasensor. The aptamers-functionalized 
nanosensor was then used for the selective capturing of rHuEPO from aqueous medium 
followed by the direct SERS detection of the captured protein. To acquire the native Raman 
fingerprint of rHu-EPO, we dropped 10 nM rHuEPO over a pristine pAu/AuNS surface and 
allowed it to dry in inert atmosphere. The subsequent SERS spectrum rHuEPO over non-
functionalized surface is depicted in Figure 23A(I). It is well known that the amide and 
aromatic (phenylalanine, tyrosine, tryptophan and histidine) vibrational bands dominate the 
Raman spectrum of proteins and polypeptides.[154, 185-190] Similarly, the SERS spectrum of 
pAu/AuNS/rHuEPO (Figure 23A(I)) showed intense bands at 1636 cm-1 and 1228 cm-1 
corresponding to amide I and amide III vibrational modes, respectively.[154, 185-190] The amide 
I @ 1636 cm-1 band represents a unique fingerprint of proteins, as it does not overlap with 
other vibrational modes from other functional groups. Therefore it can be used as a marker 
band for the identification of proteins without any external Raman labelling.[189, 191]  
 
The bands @ 1591 cm-1 and 1024 cm-1 correspond to the aromatic amino acid vibrational 
modes. Figure 23A(II) depicts the SERS spectrum of EPO aptamer on nanostructured surface. 
Figure 23 - SERS spectra of A) (I) pAu/AuNS/rHuEPO (drop dry), (II) pAu/AuNS/Apt (self-assembled
monolayer), and (III) pAu/AuNS/Apt/rHuEPO (selectively captured). B) SERS spectra of pAu/AuNS/Apt
incubated in (I) blank horse plasma and (II) rHuEPO spiked horse plasma. Each spectrum is the average
of 10 spectra.  
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The SERS spectrum of an aptamer is usually dominated by adenine and guanine as the order 
of SERS cross-section is adenine>guanine>cytosine>thymine.[192, 193] Figure 23A(II) clearly 
indicated that the SERS spectrum of aptasensor is heavily dominated by the guanine 
vibrational modes @ 647 cm-1, 1489 cm-1 and 1568 cm-1. This is because the EPO aptamer 
has higher contribution from guanine nucleobase than adenine (13:5). Also, the C-S 
stretching mode for the thiolated aptamer is depicted @ 669 cm-1. Figure 23A(III) shows the 
SERS spectrum of the apatsensor after capturing the rHuEPO protein 
(pAu/AuNS/Apt/rHuEPO) on its surface by the EPO aptamers. Scheme 2 depicts the 
graphical representation of rHuEPO captured aptasensor and subsequent SERS 
investigation. SERS The strong band @ 1676 cm-1 is attributed to the amide I vibrational 
mode.[154, 185-190] The amide I band @ 1676 cm-1 is red shifted by 40 cm-1 when compared to 
that of native rHuEPO @ 1636 cm-1 (Figure 23A(I)). Similarly, the vibrational modes of the 
aromatic amino acids @ 1603 cm-1, 1236 cm-1 and 1049 cm-1 are also red shifted. The shift in 
vibrational energy of the rHuEPO over the aptasensor surface is attributed to the aptamer 
conformational rearrangements upon binding rHuEPO to the aptamer fragment antigen 
binding (Fab) regions in the aqueous medium.[112, 194]  
 
In order to reveal the suitability of the present aptamer modified pAu/AuNS surface 
towards SERS quantification of rHuEPO, various concentrations of rHuEPO in aqueous 
medium were employed. To each concentration of rHuEPO, a freshly prepared 
pAu/AuNS/Apt surface was used to selectively capture rHuEPO onto the aptasensor surface 
Scheme 2 - Graphical representation of rHuEPO captured aptasensor and subsequent SERS investigation.
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and subsequently screened under the Raman microscope. Figure 24A shows the SERS 
spectra (amide 1 vibrational mode) of the pAu/AuNS/Apt/rHuEPO surface within a rHuEPO 
concentration range of 10 nM to 10 pM (the spectra were normalized and background 
subtracted). The band centered at 1676 cm−1 corresponding to amide I vibrational mode of 
rHuEPO was used a reference band for rHuEPO quantification. The SERS signals were found 
to monotonically decrease with decreasing concentration (Figure 24A). A linear relationship 
was obtained between the SERS signal intensity at 1676 cm−1 and the corresponding rHuEPO 
log concentration plot as depicted in Figure 24B. Similar linear relationship between 
log(concentration) and SERS intensity was formerly demonstrated in the literature.[66, 195] As 
indicated by Figure 24B, good correlation (R2 = 0.993) was found over a wide concentration 
range of rHuEPO (10−8 to 10−11 M). 
 
 Selective extraction and detection of rHuEPO in biological fluids  
As a proof of concept for the SERS detection of EPO doping in biological fluids, we 
extended our methodology towards the label-free identification of rHuEPO in horse plasma. 
1 nM rHuEPO was spiked into neat horse plasma and subsequently dropped over the 
pAu/AuNS/Apt. After 30 min, the substrate was washed with Millipore water to remove the 
biological matrix and dried in gentle flow of argon gas. A similar blank experiment was also 
carried out using un-spiked serum. Figure 23B(I) and Figure 23B(II) show the SERS spectra of 
blank and rHuEPO spiked (Figure 23B(II)), on aptasensor respectively. Figure 23B(I) shows 
strong correlation to Figure 23A(II) of the pAu/AuNS/Apt before interaction with EPO 
Figure 24 - (A) SERS spectra of pAu/AuNS/Apt/rHuEPO with decreasing concentration of rHuEPO: 10 nM
(black), 1 nM (red), 100 pM (green), and 10 pM (blue). (B) Plot demonstrating the linear relationship
between log concentration of rHuEPO and SERS intensity at 1676cm-1. 
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protein. The resemblance between Figure 23A(II) and Figure 23B(I) indicates that the 
aptasensor when interacted with blank plasma matrix (no EPO spiked in matrix) did not bind 
with any of the non EPO proteins that exist in horse plasma. This result confirms the 
selectivity of the aptasensor towards its target protein over other proteins that may co-exist 
in a biological matrix. This Figure 23B(II) clearly depicted the amide I band @ 1644 cm-1 and 
aromatic amino acid vibrations @ 1594 cm-1 and 1028 cm-1. A close comparison between 
figures Figure 23A(I) and Figure 23B(II) confirms unambiguous resemblance between the 
spectrum of rHuEPO standard and that of the aptasensor after interacting with the plasma 
sample spiked with rHuEPO. The shifts in band positions between figures Figure 23A(III) and 
Figure 23B(II) may be attributed in part to the higher dielectric constant and solvent polarity 
of aqueous matrix in comparison to those of the protein rich plasma matrix.[176] In Figure 
23A(III), the higher dielectric constant and polarity of the aqueous matrix may have caused 
the red shift of the amide I band to the higher wave number of 1676 cm-1 from its position 
at 1636 cm-1 in figures Figure 23A(I) and Figure 23B(II). Therefore, we have successfully 
demonstrated the selective extraction and SERS identification of rHuEPO in horse plasma. 
This outcome clearly indicates the significance of using aptamers-functionalized 
homogeneous SERS substrate for facile and rapid screening of proteins in biological fluids. 
The full potential of the aptasensor is realized when it is combined with handheld Raman 
device for the in-field detection of rHuEPO from biological matrices. 
 
[3.6] Conclusion 
We demonstrated a sensitive and homogenous aptasensor for the reproducible 
detection of EPO in biological fluids. Due to the close packing and homogenous distribution 
of the nanoparticles coverage over the surface, strong and reproducible signal enhancement 
is acquired especially under wide area illumination conditions where the RSD of the SERS 
measurements can be as low as 4.92%. By adapting to wide area, handheld Raman devices 
can used in combination with the new aptasensor for the label-free in-field screening of 
rHuEPO in horse plasma.   
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Summary	
Restatement of Aims: 
1. Develop a system able to (a) selectively capture, (b) detect, and (c) quantify 
biomolecules from complex biological matrices using SERS.  
2. Complement current methods for biomolecule detection by considering: (a) cost-
effectiveness; (b) analysis time; (c) ease of use; (d) detection limits and; (e) 
portability. 
 
Gold-coated iron oxide nanoparticles functionalised with anti-rHuEPO antibody and 
successfully used to selectively extract rHuEPO from a horse blood plasma matrix (Aim 1a). 
The presence of rHuEPO was detected indirectly through changes in the SERS spectrum of 
the functionalised nanoparticles after the antibody-antigen binding event (Aim 1b). The 
direct SERS spectrum of rHuEPO extracted from a biological matrix was demonstrated for 
the first time (Aim 1b). The identity of the extracted rHuEPO was confirmed and quantitated 
by ELISA (Aim 1a). Direct, label-free SERS quantitation was carried out on extracted rHuEPO 
protein after release from the antibody, with the Raman shift at 1551 cm-1 showing a linear 
relationship between signal intensity and log concentration (Aim 1c). The detection limit for 
this technique was found to be 10-12 M (Aim 2d). The iron oxide core was utilised to 
expedite the extraction process via magnetic separation (Aim 2b) and reduce the quantity of 
gold required (Aim 2a). The analysis protocol, starting from mixture through to direct SERS 
protein spectrum, can take as little as 30 minutes (Aim 2b), and can be carried out without 
prior training (Aim 2c). The extraction protocol was successfully tested for in-field screening 
of rHuEPO using a commercially available SERS substrate and handheld Raman 
spectrometer (Aim 2e).  
Aptamer-functionalised nanostructured surfaces were developed for the selective 
and reproducible detection of EPO in biological fluids (Aim 1a, 1b). These aptasensors 
consisted of gold nanostructures potentiostatically deposited over a polished gold surface, 
followed by functionalisation using rHuEPO-specific aptamers. The strong and reproducible 
SERS signal enhancement was attributed to the close packing and homogeneous distribution 
of nanoparticles over the surface. These factors led to RSD values of the SERS 
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measurements as low as 4.92% under wide area illumination, ideal for use with handheld 
Raman devices that utilise wide area or raster scanning technologies (Aim 2e). When 
compared to the antibody-nanoparticle methodology, the aptamer-surface approach trades 
loading capacity for improved screening signal homogeneity and one-step extraction (Aim 
2b, 2c), and reduces production costs associated with the selective capture by replacing the 
costly antibodies with aptamers (Aim 2a).  
These works demonstrate the viability of label-free SERS screening of rHuEPO for 
both clinical and in-field testing, however, they are applicable to any analyte with a specific 
antibody or aptamer available. Once refined, the ability to directly detect a target protein in-
field and obtain the SERS fingerprint, which can then be confirmed against reference 
spectra, can provide rapid and incontrovertible evidence for fields such as medicine and law 
enforcement.  
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Future	work	
 The continued development of reproducible direct SERS for qualitative and 
quantitative identification of biomolecules in biological matrices remains a focal point in 
future endeavours. Exploration into antibody fragments and aptamer-based technologies is 
especially attractive, as they may provide cheaper and more longevous materials for use in 
the separation process. These experiments are currently prioritised in order to determine 
optimal separation parameters in terms of specificity, cost, and reliability. Future 
exploration into electrochemical over chemical means of sample processing are fascinating, 
and we envision, may enable streamlining and miniaturisation of the process. Cost-
effectiveness, user-friendliness, and portability remain key foci moving forward in order to 
adapt these technologies for use with a wider audience.  
  
81 
 
References	
[1] M. J. Swortwood, W. L. Hearn and A. P. DeCaprio. Cross-reactivity of designer drugs, 
including cathinone derivatives, in commercial enzyme-linked immunosorbent assays. Drug 
Testing and Analysis 2014, 6, 716-727. 
[2] T. G. Hall, I. Smukste, K. R. Bresciano, Y. Wang, D. McKearn and R. E. Savage in Identifying 
and Overcoming Matrix Effects in Drug Discovery and Development,  (Ed. D. J. Prasain), 
InTech, 2012. 
[3] M. Thevis, A. Thomas and W. Schänzer. Detecting peptidic drugs, drug candidates and 
analogs in sports doping: current status and future directions. Expert Review of Proteomics 
2014, 11, 663-673. 
[4] A. Kaviraj, E. Unlu, A. Gupta and A. El Nemr. Biomarkers of Environmental Pollutants. 
BioMed Research International 2014, 2014, 2. 
[5] R. Ravichandran. Nanotechnology Applications in Food and Food Processing: Innovative 
Green Approaches, Opportunities and Uncertainties for Global Market. International Journal 
of Green Nanotechnology: Physics and Chemistry 2010, 1, P72-P96. 
[6] N. C. Tansil and Z. Gao. Nanoparticles in biomolecular detection. Nano Today 2006, 1, 28-
37. 
[7] K. Hyonchol, T. Hideyuki, H. Masahito, T. Hiroyuki and Y. Kenji. Highly Sensitive Detection 
of Target Biomolecules on Cell Surface Using Gold Nanoparticle Conjugated with Aptamer 
Probe. Japanese Journal of Applied Physics 2012, 51, 06FH01. 
[8] S. Jin and K. Ye. Nanoparticle-Mediated Drug Delivery and Gene Therapy. Biotechnology 
Progress 2007, 23, 32-41. 
[9] E.-K. Lim, T. Kim, S. Paik, S. Haam, Y.-M. Huh and K. Lee. Nanomaterials for Theranostics: 
Recent Advances and Future Challenges. Chemical Reviews 2015, 115, 327-394. 
[10] S.-H. Tseng, M.-Y. Chou and I. M. Chu. Cetuximab-conjugated iron oxide nanoparticles 
for cancer imaging and therapy. International Journal of Nanomedicine 2015, 10, 3663-3685. 
[11] D. R. Shankaran, K. V. Gobi and N. Miura. Recent advancements in surface plasmon 
resonance immunosensors for detection of small molecules of biomedical, food and 
environmental interest. Sensors and Actuators B: Chemical 2007, 121, 158-177. 
[12] T. J. Crisman, C. N. Parker, J. L. Jenkins, J. Scheiber, M. Thoma, Z. B. Kang, R. Kim, A. 
Bender, J. H. Nettles, J. W. Davies and M. Glick. Understanding false positives in reporter 
gene assays: in silico chemogenomics approaches to prioritize cell-based HTS data. J Chem 
Inf Model 2007, 47, 1319-1327. 
[13] J. Wang and X. Qu. Recent progress in nanosensors for sensitive detection of 
biomolecules. Nanoscale 2013, 5, 3589-3600. 
[14] R. van der Oost, J. Beyer and N. P. E. Vermeulen. Fish bioaccumulation and biomarkers 
in environmental risk assessment: a review. Environmental Toxicology and Pharmacology 
2003, 13, 57-149. 
[15] J. E. Anderson, L. L. Hansen, F. C. Mooren, M. Post, H. Hug, A. Zuse and M. Los. Methods 
and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards 
personalized medicine. Drug Resist Updat 2006, 9, 198-210. 
[16] X. Lin, L. Cui, Y. Huang, Y. Lin, Y. Xie, Z. Zhu, B. Yin, X. Chen and C. J. Yang. Carbon 
nanoparticle-protected aptamers for highly sensitive and selective detection of 
biomolecules based on nuclease-assisted target recycling signal amplification. Chemical 
Communications 2014, 50, 7646-7648. 
[17] R. Mayeux. Biomarkers: Potential Uses and Limitations. NeuroRx 2004, 1, 182-188. 
82 
 
[18] J. R. Kesting, J. Huang and D. Sørensen. Identification of adulterants in a Chinese herbal 
medicine by LC–HRMS and LC–MS–SPE/NMR and comparative in vivo study with standards 
in a hypertensive rat model. Journal of Pharmaceutical and Biomedical Analysis 2010, 51, 
705-711. 
[19] M. J. Sheetz and G. L. King. Molecular understanding of hyperglycemia's adverse effects 
for diabetic complications. JAMA 2002, 288, 2579-2588. 
[20] National Institute on Drug Abuse (NIDA). Commonly Abused Drug Charts. 2016, 
https://www.drugabuse.gov/drugs-abuse/commonly-abused-drugs-charts 
[21] U.S. Department of Justice in Drugs of Abuse, Vol.  (Ed. Drug Enforcement 
Administration), https://www.dea.gov/pr/multimedia-
library/publications/drug_of_abuse.pdf, 2015. 
[22] R. I. G. Holt and P. H. Sönksen. Growth hormone, IGF-I and insulin and their abuse in 
sport. British Journal of Pharmacology 2008, 154, 542-556. 
[23] B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts and P. Walter. Molecular Biology of 
the Cell, Gardland Science, New York, 2002, p. 
[24] B. Maity, D. Sheff and R. A. Fisher. Immunostaining: detection of signaling protein 
location in tissues, cells and subcellular compartments. Methods Cell Biol 2013, 113, 81-105. 
[25] Abcam. Troubleshooting tips and tricks for IHC and ICC, as well as a detailed description 
of suitable positive and negative controls for both techniques. 2016, 
http://www.abcam.com/protocols/troubleshooting-and-using-controls-in-ihc-and-icc 
[26] A. Adan, G. Alizada, Y. Kiraz, Y. Baran and A. Nalbant. Flow cytometry: basic principles 
and applications. Critical Reviews in Biotechnology 2016, 1-14. 
[27] H. Lodish, A. Berk and S. L. Zipursky in Molecular Cell Biology. 4th Edition. ,  W. H. 
Freeman, New York, 2000. 
[28] E. Uliyanchenko. Size-exclusion chromatography—from high-performance to ultra-
performance. Analytical and Bioanalytical Chemistry 2014, 406, 6087-6094. 
[29] GE Healthcare. Ion Exchange Chromatography. 2016, 
http://www.gelifesciences.com/file_source/GELS/Service%20and%20Support/Documents%
20and%20Downloads/Handbooks/pdfs/Ion%20Exchange%20Chromatography.pdf 
[30] J. A. Queiroz, C. T. Tomaz and J. M. S. Cabral. Hydrophobic interaction chromatography 
of proteins. Journal of Biotechnology 2001, 87, 143-159. 
[31] C. C. Chery, L. Moens, R. Cornelis and F. Vanhaecke. Capabilities and limitations of gel 
electrophoresis for elemental speciation: A laboratory’s experience. Pure Applied Chemistry 
2006, 78, 91-103. 
[32] T. Rabilloud, A. R. Vaezzadeh, N. Potier, C. Lelong, E. Leize-Wagner and M. Chevallet. 
Power and limitations of electrophoretic separations in proteomics strategies. Mass 
Spectrom Rev 2009, 28, 816-843. 
[33] B. Byrne, E. Stack, N. Gilmartin and R. O’Kennedy. Antibody-Based Sensors: Principles, 
Problems and Potential for Detection of Pathogens and Associated Toxins. Sensors 2009, 9, 
4407. 
[34] S. Zhang, A. Garcia-D'Angeli, J. P. Brennan and Q. Huo. Predicting detection limits of 
enzyme-linked immunosorbent assay (ELISA) and bioanalytical techniques in general. 
Analyst 2014, 139, 439-445. 
[35] B. L. Milman. General principles of identification by mass spectrometry. TrAC Trends in 
Analytical Chemistry 2015, 69, 24-33. 
[36] R. Knochenmuss. Ion formation mechanisms in UV-MALDI. Analyst 2006, 131, 966-986. 
83 
 
[37] M. S. Hanay, S. Kelber, A. K. Naik, D. Chi, S. Hentz, E. C. Bullard, E. Colinet, L. Duraffourg 
and M. L. Roukes. Single-protein nanomechanical mass spectrometry in real time. Nat Nano 
2012, 7, 602-608. 
[38] U. Gala and H. Chauhan. Principles and applications of Raman spectroscopy in 
pharmaceutical drug discovery and development. Expert Opin Drug Discov 2015, 10, 187-
206. 
[39] M. B. Fenn, P. Xanthopoulos, G. Pyrgiotakis, S. R. Grobmyer, P. M. Pardalos and L. L. 
Hench. Raman Spectroscopy for Clinical Oncology. Advances in Optical Technologies 2011, 
2011. 
[40] E. C. Le Ru and P. G. Etchegoin in Chapter 4 - SERS enhancement factors and related 
topics,  Eds.: E. C. L. Ru and P. G. Etchegoin), Elsevier, Amsterdam, 2009, pp. 185-264. 
[41] E. C. Le Ru, E. Blackie, M. Meyer and P. G. Etchegoin. Surface Enhanced Raman 
Scattering Enhancement Factors:  A Comprehensive Study. The Journal of Physical Chemistry 
C 2007, 111, 13794-13803. 
[42] S. Nie and S. R. Emory. Probing Single Molecules and Single Nanoparticles by Surface-
Enhanced Raman Scattering. Science 1997, 275, 1102-1106. 
[43] V. I. Kukushkin, A. B. Van'kov and I. V. Kukushkin. Long-range manifestation of surface-
enhanced Raman scattering. JETP Letters 2013, 98, 5. 
[44] S. Y. Huang, B.-I. Wu, B. Zhang, Y. H. Lee, V. Liberman and M. Rothschild. An analytical 
method to study the effects of a substrate in surface-enhanced Raman scattering. Journal of 
Applied Physics 2009, 106, 114306-114312. 
[45] A. Sivanesan, J. Kozuch, H. K. Ly, G. Kalaivani, A. Fischer and I. M. Weidinger. Tailored 
silica coated Ag nanoparticles for non-invasive surface enhanced Raman spectroscopy of 
biomolecular targets. RSC Advances 2012, 2, 805-808. 
[46] J. A. Creighton and D. G. Eadon. Ultraviolet-visible absorption spectra of the colloidal 
metallic elements. Journal of the Chemical Society, Faraday Transactions 1991, 87, 3881-
3891. 
[47] E. Petryayeva and U. J. Krull. Localized surface plasmon resonance: Nanostructures, 
bioassays and biosensing—A review. Analytica Chimica Acta 2011, 706, 8-24. 
[48] K. A. Willets and R. P. Van Duyne. Localized surface plasmon resonance spectroscopy 
and sensing. Annu Rev Phys Chem 2007, 58, 267-297. 
[49] M. M. Kathryn, H. Feng, L. Seunghyun, N. Peter and H. H. Jason. A single molecule 
immunoassay by localized surface plasmon resonance. Nanotechnology 2010, 21, 255503. 
[50] Y. Kitahama and Y. Ozaki in Analysis of Blinking SERS by a Power Law with an 
Exponential Function,  John Wiley & Sons, Ltd, 2014, pp. 107-137. 
[51] J. R. Lombardi, R. L. Birke and G. Haran. Single Molecule SERS Spectral Blinking and 
Vibronic Coupling. The Journal of Physical Chemistry C 2011, 115, 4540-4545. 
[52] N. D. Israelsen, C. Hanson and E. Vargis. Nanoparticle Properties and Synthesis Effects 
on Surface-Enhanced Raman Scattering Enhancement Factor: An Introduction. The Scientific 
World Journal 2015, 2015, 12. 
[53] E. D. Getzoff, H. M. Geysen, S. J. Rodda, H. Alexander, J. A. Tainer and R. A. Lerner. 
Mechanisms of antibody binding to a protein. Science 1987, 235, 1191-1196. 
[54] C. A. Janeway Jr, P. Travers and M. Walport in The generation of diversity in 
immunoglobulins,  Garland Science, New York, 2001. 
[55] M. Oda. Review Antibody flexibility observed in antigen binding and its subsequent 
signaling. Journal of Biological Macromolecules 2004, 4, 45-56. 
84 
 
[56] T. Sagawa, M. Oda, H. Morii, H. Takizawa, H. Kozono and T. Azuma. Conformational 
changes in the antibody constant domains upon hapten-binding. Mol Immunol 2005, 42, 9-
18. 
[57] C. A. Janeway Jr, P. Travers and M. Walport in The interaction of the antibody molecule 
with specific antigen,  Garland Science, New York, 2001. 
[58] A. L. Nelson. Antibody fragments: Hope and hype. mAbs 2010, 2, 77-83. 
[59] F. Li, H. Zhang, Z. Wang, A. M. Newbigging, M. S. Reid, X.-F. Li and X. C. Le. Aptamers 
Facilitating Amplified Detection of Biomolecules. Analytical Chemistry 2015, 87, 274-292. 
[60] P.-H. Lin, R.-H. Chen, C.-H. Lee, Y. Chang, C.-S. Chen and W.-Y. Chen. Studies of the 
binding mechanism between aptamers and thrombin by circular dichroism, surface plasmon 
resonance and isothermal titration calorimetry. Colloids and Surfaces B: Biointerfaces 2011, 
88, 552-558. 
[61] G. Mayer. The Chemical Biology of Aptamers. Angewandte Chemie International Edition 
2009, 48, 2672-2689. 
[62] S. Kedzierski, M. Khoshnejad and G. T. Caltagirone. Synthetic Antibodies: The Emerging 
Field of Aptamers. BioProcessing Journal 2012, 11, 46-49. 
[63] P. H. C. Carmago, K. G. Satyanarayana and F. Wypych. Nanocomposites: Synthesis, 
Structure, Properties and New Application Opportunities. Materials Research 2009, 12, 39. 
[64] T. L. Vasconcelos, B. S. Archanjo, B. Fragneaud, B. S. Oliveira, J. Riikonen, C. Li, D. S. 
Ribeiro, C. Rabelo, W. N. Rodrigues, A. Jorio, C. A. Achete and L. G. Cançado. Tuning 
Localized Surface Plasmon Resonance in Scanning Near-Field Optical Microscopy Probes. 
ACS Nano 2015, 9, 6297-6304. 
[65] M. Nicklaus. Tip-Enhanced Raman Spectroscopy for Nanoelectronics, Books on Demand, 
2014, p. 26. 
[66] A. K. M. Jamil, E. L. Izake, A. Sivanesan, R. Agoston and G. A. Ayoko. A homogeneous 
surface-enhanced Raman scattering platform for ultra-trace detection of trinitrotoluene in 
the environment. Analytical Methods 2015, 7, 3863-3868. 
[67] K. Das, P. Hubert and S. Vengallatore. Patterning Nanomaterials on Fragile 
Micromachined Structures using Electron Beam Lithography. MRS Online Proceedings 
Library 2011, 1299, null-null. 
[68] H. Yin, C. Wang, H. Zhu, S. H. Overbury, S. Sun and S. Dai. Colloidal deposition synthesis 
of supported gold nanocatalysts based on Au-Fe3O4 dumbbell nanoparticles. Chemical 
Communications 2008, 4357-4359. 
[69] M. Bardosova and T. Wagner. Nanomaterials and Nanoarchitectures: A Complex Review 
of Current Hot Topics and their Applications, Springer Netherlands, 2015, p. 
[70] A. K. M. Jamil, E. L. Izake, A. Sivanesan and P. M. Fredericks. Rapid detection of TNT in 
aqueous media by selective label free surface enhanced Raman spectroscopy. Talanta 2015, 
134, 732-738. 
[71] R. Hanna, R. Jerzy, G. Iwona and K. t. Katarzyna in Electrochemical Sensors and 
Biosensors Based on Self-Assembled Monolayers: Application of Nanoparticles for Analytical 
Signals Amplification, Vol. 1112 American Chemical Society, 2012, pp. 293-312. 
[72] L. Haeussling, H. Ringsdorf, F. J. Schmitt and W. Knoll. Biotin-functionalized self-
assembled monolayers on gold: surface plasmon optical studies of specific recognition 
reactions. Langmuir 1991, 7, 1837-1840. 
[73] I. Fratoddi, I. Venditti, C. Cametti and M. V. Russo. The puzzle of toxicity of gold 
nanoparticles. The case-study of HeLa cells. Toxicology Research 2015, 4, 796-800. 
85 
 
[74] R. Coradeghini, S. Gioria, C. P. García, P. Nativo, F. Franchini, D. Gilliland, J. Ponti and F. 
Rossi. Size-dependent toxicity and cell interaction mechanisms of gold nanoparticles on 
mouse fibroblasts. Toxicology Letters 2013, 217, 205-216. 
[75] R. Shukla, V. Bansal, M. Chaudhary, A. Basu, R. R. Bhonde and M. Sastry. 
Biocompatibility of Gold Nanoparticles and Their Endocytotic Fate Inside the Cellular 
Compartment: A Microscopic Overview. Langmuir 2005, 21, 10644-10654. 
[76] Z. Fan, M. Shelton, A. K. Singh, D. Senapati, S. A. Khan and P. C. Ray. Multifunctional 
Plasmonic Shell–Magnetic Core Nanoparticles for Targeted Diagnostics, Isolation, and 
Photothermal Destruction of Tumor Cells. ACS Nano 2012, 6, 1065-1073. 
[77] M. Hu, J. Chen, Z.-Y. Li, L. Au, G. V. Hartland, X. Li, M. Marquez and Y. Xia. Gold 
nanostructures: engineering their plasmonic properties for biomedical applications. 
Chemical Society Reviews 2006, 35, 1084-1094. 
[78] P. Tiwari, K. Vig, V. Dennis and S. Singh. Functionalized Gold Nanoparticles and Their 
Biomedical Applications. Nanomaterials 2011, 1, 31. 
[79] F. Chen, X. Li, J. Hihath, Z. Huang and N. Tao. Effect of Anchoring Groups on Single-
Molecule Conductance:  Comparative Study of Thiol-, Amine-, and Carboxylic-Acid-
Terminated Molecules. Journal of the American Chemical Society 2006, 128, 15874-15881. 
[80] M. Mahmoudi, A. Simchi, A. S. Milani and P. Stroeve. Cell toxicity of superparamagnetic 
iron oxide nanoparticles. Journal of Colloid and Interface Science 2009, 336, 510-518. 
[81] Z. Xu, Y. Hou and S. Sun. Magnetic Core/Shell Fe3O4/Au and Fe3O4/Au/Ag 
Nanoparticles with Tunable Plasmonic Properties. Journal of the American Chemical Society 
2007, 129, 8698-8699. 
[82] S. Zong, Z. Wang, H. Chen, G. Hu, M. Liu, P. Chen and Y. Cui. Colorimetry and SERS dual-
mode detection of telomerase activity: combining rapid screening with high sensitivity. 
Nanoscale 2014, 6, 1808-1816. 
[83] V. Amendola, S. Scaramuzza, L. Litti, M. Meneghetti, G. Zuccolotto, A. Rosato, E. 
Nicolato, P. Marzola, G. Fracasso, C. Anselmi, M. Pinto and M. Colombatti. Magneto-
Plasmonic Au-Fe Alloy Nanoparticles Designed for Multimodal SERS-MRI-CT Imaging. Small 
2014, 10, 2476-2486. 
[84] E. Çelik, P. Çalık, S. M. Halloran and S. G. Oliver. Production of recombinant human 
erythropoietin from Pichia pastoris and its structural analysis. Journal of Applied 
Microbiology 2007, 103, 2084-2094. 
[85] N. Robinson, S. Giraud, C. Saudan, N. Baume, L. Avois, P. Mangin and M. Saugy. 
Erythropoietin and blood doping. British Journal of Sports Medicine 2006, 40, i30-i34. 
[86] R. J. Woods in Image of the predicted structure of glycosylated human Erythropoietin, 
Vol. 359 x 335 px (Ed. glycosylated_EPO_new_r70.png), glycam.org, 2014. 
[87] T. Lappin. The Cellular Biology of Erythropoietin Receptors. The Oncologist 2003, 8, 15-
18. 
[88] World Anti-Doping Agency. A brief History of Anti-Doping. 2015, https://www.wada-
ama.org/en/who-we-are/a-brief-history-of-anti-doping 
[89] L.-J. Xu, C. Zong, X.-S. Zheng, P. Hu, J.-M. Feng and B. Ren. Label-Free Detection of 
Native Proteins by Surface-Enhanced Raman Spectroscopy Using Iodide-Modified 
Nanoparticles. Analytical Chemistry 2014, 86, 2238-2245. 
[90] A. M. Schwartzberg, C. D. Grant, A. Wolcott, C. E. Talley, T. R. Huser, R. Bogomolni and J. 
Z. Zhang. Unique Gold Nanoparticle Aggregates as a Highly Active Surface-Enhanced Raman 
Scattering Substrate. The Journal of Physical Chemistry B 2004, 108, 19191-19197. 
86 
 
[91] J. Zhou, K. Ren, Y. Zhao, W. Dai and H. Wu. Convenient formation of nanoparticle 
aggregates on microfluidic chips for highly sensitive SERS detection of biomolecules. 
Analytical and Bioanalytical Chemistry 2012, 402, 1601-1609. 
[92] D. Tang, J. C. Sauceda, Z. Lin, S. Ott, E. Basova, I. Goryacheva, S. Biselli, J. Lin, R. Niessner 
and D. Knopp. Magnetic nanogold microspheres-based lateral-flow immunodipstick for 
rapid detection of aflatoxin B2 in food. Biosensors and Bioelectronics 2009, 25, 514-518. 
[93] A. C. Manikas, F. Causa, R. Della Moglie and P. A. Netti. Tuning Gold Nanoparticles 
Interfaces by Specific Peptide Interaction for Surface Enhanced Raman Spectroscopy (SERS) 
and Separation Applications. ACS Applied Materials & Interfaces 2013, 5, 7915-7922. 
[94] G. G. Huang, M. K. Hossain, X. X. Han and Y. Ozaki. A novel reversed reporting agent 
method for surface-enhanced Raman scattering; highly sensitive detection of glutathione in 
aqueous solutions. Analyst 2009, 134, 2468-2474. 
[95] U. Tamer, D. Cetin, Z. Suludere, I. H. Boyaci, H. T. Temiz, H. Yegenoglu, P. Daniel, İ. 
Dinçer and Y. Elerman. Gold-Coated Iron Composite Nanospheres Targeted the Detection of 
Escherichia coli. International Journal of Molecular Sciences 2013, 14, 6223-6240. 
[96] M. Kumagai, T. K. Sarma, H. Cabral, S. Kaida, M. Sekino, N. Herlambang, K. Osada, M. R. 
Kano, N. Nishiyama and K. Kataoka. Enhanced in vivo Magnetic Resonance Imaging of 
Tumors by PEGylated Iron-Oxide–Gold Core–Shell Nanoparticles with Prolonged Blood 
Circulation Properties. Macromolecular Rapid Communications 2010, 31, 1521-1528. 
[97] L. Zhang, J. Xu, L. Mi, H. Gong, S. Jiang and Q. Yu. Multifunctional magnetic–plasmonic 
nanoparticles for fast concentration and sensitive detection of bacteria using SERS. 
Biosensors and Bioelectronics 2012, 31, 130-136. 
[98] Y. Hu and Y. Sun. Stable Magnetic Hot Spots for Simultaneous Concentration and 
Ultrasensitive Surface-Enhanced Raman Scattering Detection of Solution Analytes. The 
Journal of Physical Chemistry C 2012, 116, 13329-13335. 
[99] L. Lou, K. Yu, Z. Zhang, R. Huang, J. Zhu, Y. Wang and Z. Zhu. Dual-mode protein 
detection based on Fe3O4-Au hybrid nanoparticles. Nano Research 2012, 5, 272-282. 
[100] A. Zengin, U. Tamer and T. Caykara. A SERS-Based Sandwich Assay for Ultrasensitive 
and Selective Detection of Alzheimer’s Tau Protein. Biomacromolecules 2013, 14, 3001-
3009. 
[101] P. Quaresma, I. Osorio, G. Doria, P. A. Carvalho, A. Pereira, J. Langer, J. P. Araujo, I. 
Pastoriza-Santos, L. M. Liz-Marzan, R. Franco, P. V. Baptista and E. Pereira. Star-shaped 
magnetite@gold nanoparticles for protein magnetic separation and SERS detection. RSC 
Advances 2014, 4, 3659-3667. 
[102] L. Lin, E. Crew, H. Yan, S. Shan, Z. Skeete, D. Mott, T. Krentsel, J. Yin, N. A. Chernova, J. 
Luo, M. H. Engelhard, C. Wang, Q. Li and C.-J. Zhong. Bifunctional nanoparticles for SERS 
monitoring and magnetic intervention of assembly and enzyme cutting of DNAs. Journal of 
Materials Chemistry B 2013, 1, 4320-4330. 
[103] J. Baniukevic, I. Hakki Boyaci, A. Goktug Bozkurt, U. Tamer, A. Ramanavicius and A. 
Ramanaviciene. Magnetic gold nanoparticles in SERS-based sandwich immunoassay for 
antigen detection by well oriented antibodies. Biosensors and Bioelectronics 2013, 43, 281-
288. 
[104] B. Guven, N. Basaran-Akgul, E. Temur, U. Tamer and I. H. Boyac. SERS-based sandwich 
immunoassay using antibody coated magnetic nanoparticles for Escherichia coli 
enumeration. Analyst 2011, 136, 740-748. 
87 
 
[105] E. Temur, A. Zengin, İ. H. Boyacı, F. C. Dudak, H. Torul and U. Tamer. Attomole 
Sensitivity of Staphylococcal Enterotoxin B Detection Using an Aptamer-Modified Surface-
Enhanced Raman Scattering Probe. Analytical Chemistry 2012, 84, 10600-10606. 
[106] H. Zhang, X. Ma, Y. Liu, N. Duan, S. Wu, Z. Wang and B. Xu. Gold nanoparticles 
enhanced SERS aptasensor for the simultaneous detection of Salmonella typhimurium and 
Staphylococcus aureus. Biosensors and Bioelectronics 2015, 74, 872-877. 
[107] F. Bao, J.-L. Yao and R.-A. Gu. Synthesis of Magnetic Fe2O3/Au Core/Shell 
Nanoparticles for Bioseparation and Immunoassay Based on Surface-Enhanced Raman 
Spectroscopy. Langmuir 2009, 25, 10782-10787. 
[108] Y. Wang, S. Ravindranath and J. Irudayaraj. Separation and detection of multiple 
pathogens in a food matrix by magnetic SERS nanoprobes. Analytical and Bioanalytical 
Chemistry 2011, 399, 1271-1278. 
[109] J. Yoon, N. Choi, J. Ko, K. Kim, S. Lee and J. Choo. Highly sensitive detection of 
thrombin using SERS-based magnetic aptasensors. Biosensors and Bioelectronics 2013, 47, 
62-67. 
[110] T. Demeritte, B. P. Viraka Nellore, R. Kanchanapally, S. S. Sinha, A. Pramanik, S. R. 
Chavva and P. C. Ray. Hybrid Graphene Oxide Based Plasmonic-Magnetic Multifunctional 
Nanoplatform for Selective Separation and Label-Free Identification of Alzheimer’s Disease 
Biomarkers. ACS Applied Materials & Interfaces 2015, 7, 13693-13700. 
[111] Z. Fan, D. Senapati, S. A. Khan, A. K. Singh, A. Hamme, B. Yust, D. Sardar and P. C. Ray. 
Popcorn-Shaped Magnetic Core–Plasmonic Shell Multifunctional Nanoparticles for the 
Targeted Magnetic Separation and Enrichment, Label-Free SERS Imaging, and Photothermal 
Destruction of Multidrug-Resistant Bacteria. Chemistry – A European Journal 2013, 19, 2839-
2847. 
[112] J. Hughes, E. L. Izake, W. B. Lott, G. A. Ayoko and M. Sillence. Ultra sensitive label free 
surface enhanced Raman spectroscopy method for the detection of biomolecules. Talanta 
2014, 130, 20-25. 
[113] I. Finoulst, M. Pinkse, W. Van Dongen and P. Verhaert. Sample Preparation Techniques 
for the Untargeted LC-MS-Based Discovery of Peptides in Complex Biological Matrices. 
Journal of Biomedicine and Biotechnology 2011, 2011. 
[114] N. Miekus, I. Oledzka, A. Plenis, Z. Wozniak, A. Lewczuk, P. Koszalka, B. Seroczynska 
and T. Baczek. Gel electrophoretic separation of proteins from cultured neuroendocrine 
tumor cell lines. Molecular Medicine Reports 2015, 11, 1407+. 
[115] H. Mirzaei and F. Regnier. Structure specific chromatographic selection in targeted 
proteomics. Journal of Chromatography B 2005, 817, 23-34. 
[116] A. Poliwoda and P. Wieczorek. Sample pretreatment techniques for oligopeptide 
analysis from natural sources. Analytical and Bioanalytical Chemistry 2009, 393, 885-897. 
[117] C. Seger. Usage and limitations of liquid chromatography-tandem mass spectrometry 
(LC–MS/MS) in clinical routine laboratories. Wiener Medizinische Wochenschrift 2012, 162, 
499-504. 
[118] P. J. Tighe, R. R. Ryder, I. Todd and L. C. Fairclough. ELISA in the multiplex era: 
Potentials and pitfalls. PROTEOMICS – Clinical Applications 2015, 9, 406-422. 
[119] P. E. Groleau, P. Desharnais, L. Coté and C. Ayotte. Low LC-MS/MS detection of 
glycopeptides released from pmol levels of recombinant erythropoietin using nanoflow 
HPLC-chip electrospray ionization. Journal of Mass Spectrometry 2008, 43, 924-935. 
[120] F. Guan, C. E. Uboh, L. R. Soma, E. Birks, J. Chen, Y. You, J. Rudy and X. Li. 
Differentiation and Identification of Recombinant Human Erythropoietin and Darbepoetin 
88 
 
Alfa in Equine Plasma by LC−MS/MS for Doping Control. Analytical Chemistry 2008, 80, 
3811-3817. 
[121] Thermo Scientific. 1602127-Assay-Development-Handbook. 2014, 
https://tools.thermofisher.com/content/sfs/brochures/1602127-Assay-Development-
Handbook.pdf 
[122] X. X. Han, B. Zhao and Y. Ozaki. Surface‐enhanced Raman scattering for protein 
detection. Anal. Bioanal. Chem. 2009, 394, 1719. 
[123] K. Hering, D. Cialla, K. Ackermann, T. Dörfer, R. Möller, H. Schneidewind, R. Mattheis, 
W. Fritzsche, P. Rösch and J. Popp. SERS: a versatile tool in chemical and biochemical 
diagnostics. Analytical and Bioanalytical Chemistry 2008, 390, 113-124. 
[124] A. Sivanesan, H. K. Ly, J. Kozuch, M. Sezer, U. Kuhlmann, A. Fischer and I. M. 
Weidinger. Functionalized Ag nanoparticles with tunable optical properties for selective 
protein analysis. Chemical Communications 2011, 47, 3553-3555. 
[125] A. Campion and P. Kambhampati. Surface-enhanced Raman scattering. Chemical 
Society Reviews 1998, 27, 241-250. 
[126] C. L. Haynes, A. D. McFarland and R. P. Van Duyne. Surface-Enhanced Raman 
Spectroscopy. Analytical Chemistry 2005, 77, 338A-346A. 
[127] J. Qi, P. Motwani, M. Gheewala, C. Brennan, J. C. Wolfe and W.-C. Shih. Surface-
enhanced Raman spectroscopy with monolithic nanoporous gold disk substrates. Nanoscale 
2013, 5, 4105-4109. 
[128] K. C. Bantz, A. F. Meyer, N. J. Wittenberg, H. Im, O. Kurtulus and S. H. Lee. Recent 
progress in SERS biosensing. Physical Chemistry Chemical Physics 2011, 13, 11551-11567. 
[129] E. Podstawka, Y. Ozaki and L. M. Proniewicz. Part III: surface-enhanced Raman 
scattering of amino acids and their homo dipeptide monolayers deposited onto colloidal 
gold surface. Applied Spectroscopy 2005, 59, 1516-1525. 
[130] A. Sivanesan, E. Izake, R. Agoston, G. Ayoko and M. Sillence. Reproducible and label-
free biosensor for the selective extraction and rapid detection of proteins in biological fluids. 
Journal of Nanobiotechnology 2015, 13, 43. 
[131] J. W. Regulation of erythropoietin production. J Physiology 2011, 589, 1251-1258. 
[132] S. Lamon, N. Robinson and M. Saugy. Procedures for monitoring recombinant 
erythropoietin and analogs in doping. Endocrinol Metab Clin North Am 2010, 39. 
[133] J. Morkeberg, C. Lundby, G. R. O. Nissen-Lie, T. K. Nielsen, P. Hemmersbach and R. 
Damsgaard. Detection of darbepoetin alfa misuse in urine and blood: a preliminary 
investigation. Med Sci Sports Exerc 2007, 39, 1742-1747. 
[134] G. R. O. Nissen-Lie, K. Birkeland, P. Hemmersbach and V. Skibeli. Serum sTfR Levels 
May Indicate Charge Profiling of Urinary r-hEPO in Doping Control. Med Sci Sports Exerc 
2004, 36, 588-593. 
[135] M. Ashenden, E. Varlet-Marie, F. Lasne and M. Audran. The effects of microdose 
recombinant human erythropoietin regimens in athletes. Haematologica 2006, 91, 1143-
1144. 
[136] WADA EPO Working Group in WADA Technical Document – TD2014EPO, Vol.  (Ed. 
World Anti-Doping Agency), https://wada-main-
prod.s3.amazonaws.com/resources/files/WADA-TD2014EPO-v1-Harmonization-of-Analysis-
and-Reporting-of-ESAs-by-Electrophoretic-Techniques-EN.pdf, 2014. 
[137] Y. O. Schumacher, M. Saugy, T. Pottgiesser and N. Ronbinson. Detection of EPO doping 
and blood doping: the haematological module of the Athlete Biological Passport. Drug 
Testing and Analysis 2012, 4, 846-854. 
89 
 
[138] D. Ciallaa, S. Polloka, C. Steinbrucker, K. Weber and J. Popp. SERS-based detection of 
biomolecules. Nanophotonics 2014, 3, 383-411. 
[139] Ocean Optics. High Quality Raman Data for Non-Homogeneous Samples Using Raster 
Orbital Scanning. 2014, http://oceanoptics.com/wp-content/uploads/App-Note-High-
Quality-Raman-Data-for-Non-Homogeneous-Samples-Using-Raster-Orbital-Scanning.pdf 
[140] P. K. Jain, Y. Xiao, R. Walsworth and A. E. Cohen. Surface plasmon resonance enhanced 
magneto (SuPREMO): Faraday rotation enhancement in gold-coated iron oxide nanocrystals. 
Nano Letters 2009, 4, 1644-1650. 
[141] U. Tamer, Y. Gündoğdu, İ. Boyacı and K. Pekmez. Synthesis of magnetic core–shell 
Fe3O4–Au nanoparticle for biomolecule immobilization and detection. Journal of 
Nanoparticle Research 2010, 12, 1187-1196. 
[142] A. Sharma, Z. Matharu, G. Sumana, P. R. Solanki, C. G. Kim and B. D. Malhotra. 
Antibody immobilized cysteamine functionalized-gold nanoparticles for aflatoxin detection. 
Thin Solid Films 2010, 519, 1213-1218. 
[143] T. Yannick, A. Brioude, A. W. Coleman, M. Rhimi and B. Kim. Molecular recognition by 
gold, silver and copper nanoparticles. World Journal of Biological Chemistry 2013, 4, 35-63. 
[144] W. Wang, Q. Wei, J. Wang, B. Wang, S. Zhang and Z. Yuan. Role of thiol-containing 
polyethylene glycol (thiol-PEG) in the modification process of gold nanoparticles (AuNPs): 
Stabilizer or coagulant. J Colloid Interface Sci 2013, 404, 223-229. 
[145] M. Lönnberg, Y. Dehnes, M. Drevin, M. Garle, S. Lamon and N. Leuenberger. Rapid 
affinity purification of erythropoietin from biological samples using disposable monoliths. J 
Chromatogr 2010, 1217, 7031-7037. 
[146] M. S. Schmidt, J. Hübner and A. Boisen. Large Area Fabrication of Leaning Silicon 
Nanopillars for Surface Enhanced Raman Spectroscopy. Adv Mater 2012, 2012, OP11-OP18. 
[147] J. Yang, M. Palla, F. G. Bosco, T. Rindzevicius, T. S. Alstrøm and M. S. Schmidt. Surface-
enhanced Raman spectroscopy based quantitative bioassay on aptamer-functionalized 
nanopillars using large-area Raman mapping. ACS Nano 2013, 2013. 
[148] R&D Systems. Human Erythropoietin Quantikine IVD ELISA Kit: R&D Systems. 2016, 
https://www.rndsystems.com/products/human-erythropoietin-quantikine-ivd-elisa-
kit_dep00 
[149] C. Hoskins, Y. Min, M. Gueorguieva, C. McDougall, A. Volovick, P. Prentice, Z. Wang, A. 
Melzer, A. Cuschieri and L. Wang. Hybrid gold-iron oxide nanoparticles as a multifunctional 
platform for biomedical application. J Nanobiotechnol 2012, 10. 
[150] Z. Li, L. Wei, M. Y. Gao and H. Lei. One pot reaction to synthesize biocompatible 
magnetite nanoparticles. Adv Mater 2005, 17, 1001-1005. 
[151] A. K. Gupta and M. Gupta. Synthesis and surface engineering of iron oxide 
nanoparticles for biomedical applications. Biomaterials 2005, 26, 3995-4021. 
[152] J. Drbohlavova, R. Hrdy, V. Adam, R. Kizek, O. Schneeweiss and J. Hubalek. Preparation 
and Properties of Various Magnetic Nanoparticles. Sensors 2009, 9, 2352. 
[153] D. C. Rodrigues, M. L. de Souza, K. S. Souza, D. P. dos Santos, G. F. S. Andrade and M. L. 
A. Temperini. Critical assessment of enhancement factor measurements in surface-
enhanced Raman scattering on different substrates. Physical Chemistry Chemical Physics 
2015. 
[154] E. Podstawka, Y. Ozaki and L. M. Proniewicz. Adsorption of S-S containing proteins on 
a colloidal silver surface studied by surface-enhanced Raman spectroscopy. Applied 
Spectroscopy 2004, 58, 1147-1156. 
90 
 
[155] M. Kahraman and S. Wachsmann-Hogiu. Label-free and direct protein detection on 3D 
plasmonic nanovoid structures using surface-enhanced Raman scattering. Analytica Chimica 
Acta 2015, 856, 74-81. 
[156] A. K. M. Jamil, E. L. Izake, A. Sivanesan and P. M. Fredericks. Rapid detection of TNT in 
aqueous media by selective label free surface enhanced Raman spectroscopy. Talanta 2015, 
134, 732-738. 
[157] G. V. P. Kumar, R. Selvi, A. H. Kishore, T. K. Kundu and C. Narayana. Surface-Enhanced 
Raman Spectroscopic Studies of Coactivator-Associated Arginine Methyltransferase 1. The 
Journal of Physical Chemistry B 2008, 112, 6703-6707. 
[158] J. Wang, D. Lin, J. Lin, Y. Yu, Z. Huang, Y. Chen, J. Lin, S. Feng, B. Li, N. Liu and R. Chen. 
Label-free detection of serum proteins using surface-enhanced Raman spectroscopy for 
colorectal cancer screening. Journal of Biomedical Optics 2014, 19, 087003-087003. 
[159] X. Yang, C. Gu, F. Qian, Y. Li and J. Z. Zhang. Highly Sensitive Detection of Proteins and 
Bacteria in Aqueous Solution Using Surface-Enhanced Raman Scattering and Optical Fibers. 
Analytical Chemistry 2011, 83, 5888-5894. 
[160] M. Wang, M. Benford, N. Jing, G. Coté and J. Kameoka. Optofluidic device for ultra-
sensitive detection of proteins using surface-enhanced Raman spectroscopy. Microfluidics 
and Nanofluidics 2009, 6, 411-417. 
[161] C. V. Pagba, S. M. Lane, H. Cho and S. Wachsmann-Hogiu. Direct detection of aptamer-
thrombin binding via surface-enhanced Raman spectroscopy. Journal of Biomedical Optics 
2010, 15, 047006-047008. 
[162] P. P. Kundu, T. Bhowmick, G. Swapna, G. V. Pavan Kumar, V. Nagaraja and C. 
Narayana. Allosteric Transition Induced by Mg2+ Ion in a Transactivator Monitored by SERS. 
The Journal of Physical Chemistry B 2014, 118, 5322-5330. 
[163] N. J. Aachmann-Andersen, S. Just Christensen, K. Lisbjerg, P. Oturai, A. K. Meinild-
Lundby and N. H. Holstein-Rathlou. Recombinant Erythropoietin in Humans Has a Prolonged 
Effect on Circulating Erythropoietin Isoform Distribution. PLoS ONE 2014, 9. 
[164] D. Kurouski and R. P. Van Duyne. In Situ Detection and Identification of Hair Dyes 
Using Surface-Enhanced Raman Spectroscopy (SERS). Analytical Chemistry 2015, 87, 2901-
2906. 
[165] J. W. Fisher. Erythropoietin: Physiology and pharmacology update. Experimental 
Biology and Medicine 2003, 228, 1-14. 
[166] K. Jacobs, C. Shoemaker, R. Rudersdorf, S. D. Neill, R. J. Kaufman, A. Mufson, J. Seehra, 
S. S. Jones, R. Hewick, E. F. Fritsch, M. Kawakita, T. Shimizu and T. Miyake. Isolation and 
characterization of genomic and cDNA clones of human erythropoietin. Nature 1985, 313, 
806-810. 
[167] M. Henke, R. Laszig, C. Rübe, U. Schäfer, K. D. Haase, B. Schilcher, S. Mose, K. T. Beer, 
U. Burger, C. Dougherty and H. Frommhold. Erythropoietin to treat head and neck cancer 
patients with anaemia undergoing radiotherapy: Randomised, double-blind, placebo-
controlled trial. Lancet 2003, 362, 1255-1260. 
[168] R. Parisotto, M. Wu, M. J. Ashenden, K. R. Emslie, C. J. Gore, C. Howe, R. Kazlauskas, K. 
Sharpe, G. J. Trout, M. Xie and A. G. Hahn. Detection of recombinant human erythropoietin 
abuse in athletes utilizing markers of altered erythropoiesis. Haematologica 2001, 86, 128-
137. 
[169] A. G. Schache, T. Liloglou, J. M. Risk, A. Filia, T. M. Jones, J. Sheard, J. A. Woolgar, T. R. 
Helliwell, A. Triantafyllou, M. Robinson, P. Sloan, C. Harvey-Woodworth, D. Sisson and R. J. 
Shaw. Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous 
91 
 
cell carcinoma: Sensitivity, specificity, and prognostic discrimination. Clinical Cancer 
Research 2011, 17, 6262-6271. 
[170] Y. Yasuda, Y. Fujita, T. Matsuo, S. Koinuma, S. Hara, A. Tazaki, M. Onozaki, M. 
Hashimoto, T. Musha, K. Ogawa, H. Fujita, Y. Nakamura, H. Shiozaki and H. Utsumi. 
Erythropoietin regulates tumour growth of human malignancies. Carcinogenesis 2003, 24, 
1021-1029. 
[171] A. Sivanesan, J. Kozuch, H. K. Ly, G. Kalaivani, A. Fischer and I. M. Weidinger. Tailored 
silica coated Ag nanoparticles for non-invasive surface enhanced Raman spectroscopy of 
biomolecular targets. RSC Advances 2012, 2, 805-808. 
[172] A. Sivanesan, E. Witkowska, W. Adamkiewicz, Ł. Dziewit, A. Kamińska and J. Waluk. 
Nanostructured silver-gold bimetallic SERS substrates for selective identification of bacteria 
in human blood. Analyst 2014, 139, 1037-1043. 
[173] H. Ko, S. Singamaneni and V. V. Tsukruk. Nanostructured surfaces and assemblies as 
SERS media. Small 2008, 4, 1576-1599. 
[174] A. Kamińska, I. Dzicielewski, J. L. Weyher, J. Waluk, S. Gawinkowski, V. Sashuk, M. 
Fiałkowski, M. Sawicka, T. Suski, S. Porowski and R. Hołyst. Highly reproducible, stable and 
multiply regenerated surface-enhanced Raman scattering substrate for biomedical 
applications. Journal of Materials Chemistry 2011, 21, 8662-8669. 
[175] D. Natelson, Y. Li and J. B. Herzog. Nanogap structures: Combining enhanced Raman 
spectroscopy and electronic transport. Physical Chemistry Chemical Physics 2013, 15, 5262-
5275. 
[176] A. Sivanesan, W. Adamkiewicz, G. Kalaivani, A. Kamińska, J. Waluk, R. Hołyst and E. L. 
Izake. Towards improved precision in the quantification of surface-enhanced Raman 
scattering (SERS) enhancement factors: A renewed approach. Analyst 2015, 140, 489-496. 
[177] M. Mascini, I. Palchetti and S. Tombelli. Nucleic acid and peptide aptamers: 
Fundamentals and bioanalytical aspects. Angewandte Chemie - International Edition 2012, 
51, 1316-1332. 
[178] Y. C. Lim, A. Z. Kouzani and W. Duan. Aptasensors: A review. Journal of Biomedical 
Nanotechnology 2010, 6, 93-105. 
[179] L. Feng, A. Sivanesan, Z. Lyu, A. Offenhäusser and D. Mayer. Electrochemical current 
rectification-a novel signal amplification strategy for highly sensitive and selective aptamer-
based biosensor. Biosensors and Bioelectronics 2015, 66, 62-68. 
[180] J. Sun, A. Guo, Z. Zhang, L. Guo and J. Xie. A Conjugated Aptamer-Gold Nanoparticle 
Fluorescent Probe for Highly Sensitive Detection of rHuEPO-α. Sensors 2011, 11, 10490. 
[181] Z. Zhang, L. Guo, J. Tang, X. Guo and J. Xie. An aptameric molecular beacon-based 
“Signal-on” approach for rapid determination of rHuEPO-α. Talanta 2009, 80, 985-990. 
[182] N. Félidj, J. Aubard, G. Lévi, J. R. Krenn, G. Schider, A. Leitner and F. R. Aussenegg. 
Enhanced substrate-induced coupling in two-dimensional gold nanoparticle arrays. Physical 
Review B - Condensed Matter and Materials Physics 2002, 66, 2454071-2454077. 
[183] K. Shin and H. Chung. Wide area coverage Raman spectroscopy for reliable 
quantitative analysis and its applications. Analyst 2013, 138, 3335-3346. 
[184] K. Shin, K. Ryu, H. Lee, K. Kim, H. Chung and D. Sohn. Au nanoparticle-encapsulated 
hydrogel substrates for robust and reproducible SERS measurement. Analyst 2013, 138, 
932-938. 
[185] C. Blum, T. Schmid, L. Opilik, N. Metanis, S. Weidmann and R. Zenobi. Missing amide i 
mode in gap-mode tip-enhanced raman spectra of proteins. Journal of Physical Chemistry C 
2012, 116, 23061-23066. 
92 
 
[186] T. E. Keyes, D. Leane, R. J. Forster, N. Moran and D. Kenny. New insights into the 
molecular mechanisms of thrombosis from high resolution surface enhanced Raman 
microscopy. Proceedings of SPIE-the international society for optical engineering 2005. 
[187] G. V. P. Kumar, R. Selvi, A. H. Kishore, T. K. Kundu and C. Narayana. Surface-enhanced 
Raman spectroscopic studies of coactivator-associated arginine methyltransferase 1. Journal 
of Physical Chemistry B 2008, 112, 6703-6707. 
[188] P. P. Kundu, T. Bhowmick, G. Swapna, G. V. Pavan Kumar, V. Nagaraja and C. 
Narayana. Allosteric transition induced by Mg2+ ion in a transactivator monitored by SERS. 
Journal of Physical Chemistry B 2014, 118, 5322-5330. 
[189] D. Kurouski, T. Postiglione, T. Deckert-Gaudig, V. Deckert and I. K. Lednev. Amide i 
vibrational mode suppression in surface (SERS) and tip (TERS) enhanced Raman spectra of 
protein specimens. Analyst 2013, 138, 1665-1673. 
[190] P. Negri, G. Chen, A. Kage, A. Nitsche, D. Naumann, B. Xu and R. A. Dluhy. Direct 
optical detection of viral nucleoprotein binding to an anti-influenza aptamer. Analytical 
Chemistry 2012, 84, 5501-5508. 
[191] S. U. Sane, S. M. Cramer and T. M. Przybycien. A Holistic Approach to Protein 
Secondary Structure Characterization Using Amide I Band Raman Spectroscopy. Analytical 
Biochemistry 1999, 269, 255-272. 
[192] A. Barhoumi, D. Zhang, F. Tam and N. J. Halas. Surface-Enhanced Raman Spectroscopy 
of DNA. Journal of the American Chemical Society 2008, 130, 5523-5529. 
[193] Y. Lu, Q. Huang, G. Meng, L. Wu and Z. Jingjing. Label-free selective SERS detection of 
PCB-77 based on DNA aptamer modified SiO2@Au core/shell nanoparticles. Analyst 2014, 
139, 3083-3087. 
[194] K. Mantelingu, A. H. Kishore, K. Balasubramanyam, G. V. P. Kumar, M. Altaf, S. N. 
Swamy, R. Selvi, C. I. Das, C. Narayana, K. S. Rangappa and T. K. Kundu. Activation of p300 
histone acetyltransferase by small molecules altering enzyme structure: Probed by surface-
enhanced raman spectroscopy. Journal of Physical Chemistry B 2007, 111, 4527-4534. 
[195] K. K. Sen, S. K. Basu and S. K. Dutta. Binding studies of lamotrigine with sera of 
different animal species. Tropical Journal of Pharmaceutical Research 2009, 8, 409-415. 
 
 
